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The aim of the present investigation was to determine whether 
bromine has a physiological role in the mammalian body. 
For this purpose the following investigations were carried out: 
(1) Bromide levels and its possible binding to protein in the sera of 
human subjects and guinea pigs were examined. No protein bound bromine 
was found in either. The bromide ratios of red blood cells to serum and 
of the serum to C.S.F. were determined. The concentration varies 
between cells and serum in blood, but only to a limited extent, and is 
higher than in C.S.F. The blood concentration is influenced by diet. 
The bromide/chloride ratio in both serum and C.S.F. were also measured 
and was found to be different. 
The serum bromide levels in a group of schizophrenic patients 
fell within the lower half of the normal range. This was shown to be 
due to the dietary factor. 
(2) The bromide content in various tissues of man (including various 
regions of one human brain), of guinea pigs, of rabbits and of rats were 
examined by a chemical method. A radio-isotope method was also used 
but only in guinea pigs. The results showed that no tissue concentrates 
bromide preferentially, with the exception of the stomach (measured only 
in guinea pigs). No protein bound bromine was found in the pituitary. 
The prolonged aamiristration of varying amounts of bromide to 
pima pigs showed that there was a progressive accumulation of bromide 
in all organs studied, the highest being in the serum. 
The addition of fluoride to the drinking water of guinea pigs 
significantly decreased the bromide level in all tissues studied. 
This suggests that fluoride can displace bromide in tissues. 
(3) The effect of bromide and fluoride on thyroid. function was 
investigated, and the results suggest that bromide may stimulate and 
fluoride depress the production of thyroid hormone. 
(4-) The rate of bromide excretion in humans was investigated using both 
radioisotopic and chemical techniques; the results showed that there was 
very little excretion during the first 24. hours lapproximate] y 4) and 
that the average biological half-life of bromide is approximately 6 days. 
Studies also indicated that chloride is excreted. preferentially to 
bromide by the kidney. It was found that bromide is excreted. at a 
reduced rate during the night. This diurnal rhythm of bromide 
excretion follows very closely that of chloride and sodium. There was 
no definite relationship between urinary volume and bromide excretion. 
(5) Prolonged administration of bromide and. fluoride to guinea pigs 
showed no significant effect on blood components, such as sodium, 
potassium, acetyl cholinesterase and. elanine amino transf erase 
1 . 
GENERAL INTRODUCTION 
Bromide is widely distributed in soils, rock and especially 
water. It has been estimated that this element constitutes approxi-
mately 0.001 per cent of the earth's crust, and it occupies 25th place 
on the list of elements arranged in the relative order of their 
abundance. 	(1) 
Since the elements of the halogen group are generally 
associated in nature it would be expected that they are absorbed 
together by 	and animals and should therefore be presented as 
normal constituents of living tissue. The presence of chloride, iodide 
and fluoride in most living organisms has been known for some time, 
while that of bromide has been in doubt. However it is now accepted 
that bromide is present in almost all biological fluids and tissues. 
In humans and animals, the bromide content depends upon the dietary 
intake. Winnek and Smith (1937) (2) found bromide to be present in 
most foodstuffs analysed, e.g. 
Egg albumin - 94.0 jug/g 	White flour - 	5.2 - 7.9 pilg 
Milk powder - 40.0 " 	Alcoholic extract 
Whey powder - 17.3 " of wheat germ - 8.7 - 8.9 " 
Whether bromine is physiologically important to the body, or is simply 
present in the tissues and biological fluids as an accidental constituent 
ingested with all foods is still more or less unknown. 
There appears to be some disagreement as to whether bromide 
has any nutritional value. Winnek and Smith (1937) (1) reported that 
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no significant difference was found in the general appearance, food 
intake, rate of growth or reproduction record between white rats on 
a synthetic diet low in bromide and those on a synthetic diet containing 
added bromide. Huff et al. (1956) (3), on the other hand, claimed that 
there is a nutritional requirement for bromide in rats, and Bosshardt 
et al. (1956) (4) reported an 8 - 10 per cent growth response in chicks 
on diets supplemented with a bromide source. However, the above 
evidence is not conclusive as there are several factors which might 
have influenced these findings. First of all it is a known fact that 
bromide crosses the placental barrier (see Chapter on Excretion of 
Bromide) and therefore it is found in the second generation originating 
from the mother; albumin is also known to contain bromide, and in any 
case it is very difficult to obtain a diet completely free of bromide. 
Generally it could be stated that there is no evidence to 
date to show that bromide plays any physiological role in higher 
vertebrates, particularly mammals, however there have been reports 
suggesting that in some lower animals or plants, bromide may be somehow 
involved. 
Burger and Ti Li Loo (1959) (5) suggested that certain marine 
animals possess an enzyme system which catalyses the biological 
halogenation of phenols. These authors showed that the uterus of the 
pregnant spiny dogfish, Scualus acanthias, an elasmobranch, can convert 
the dye phenol red (phenolsulfonphthalein) into a purplish - blue dye, 
bromophenol blue (3, 3', 5, 5' - tetrabromophenolsulf sonphthalein). 
Ti Li Loo et al. (1963) (6) found that the activity of this 
bromination was primarily in the uterine epithelium. The optimum pH 
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for bromination of 7.4 is close to the body pH of the fish (7). After 
5 - 10 minutes of boiling, this epithelial tissue became completely 
inactive, thus indicating that an enzyme system was involved. 
These studies were extended to include several other 
phthalein dyes, namely chlorophenol red, metacresol purple, and. 
fluorescein; all of these were found to be brominated. 
There are some other examples of biological bromination in 
nature. For instance, the bromination of phenol red was also observed 
by an enzyme system isolated from the mould Caldariamyces fuzee° at 
pH 2.8 (8); the natural occurrence of bromine compounds in marine 
animals such as the shellfish Murex brandaris and. M. tranculus (9), and 
the coral fan Gorgonia verrucosa (10), indicates that enzymatic bramin - 
ation may be of importance in their biogenesis. 
It can be said that naturally occurring halogenated organic 
compounds, apart from thyroxin, are rare in animals. Therefore the 
examples cited are of great interest and argue for the existence in 
certain marine animals of an enzyme system which catalyses the bromin-
ation. According to the authors quoted biological halogenation of 
phenols may be analogous to the biogenesis of thyroxin, e in the course 
of which tyrosine residues undergo iodination. 
However, there seems to be no evidence as yet to show that 
bromide is involved in the physiology of mammals. It appears strange 
that while chlorine, fluorine and iodine all have definite physiological 
functions, there is no obvious function for bromine. 
The aim of the present investigation was therefore to consider 
some aspects of the action of bromine in the biological systems of man 
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and guinea pigs and its relationship to other halogens. 
This thesis is accordingly divided into five Chapters, each 
concerned with a different aspect of bromide investigation.. Each 
individual Chapter begins with an appropriate historical background 
before the work of the present investigation is described. The latter 
then is subdivided into aims, methods, results and conclusions, in 
which there is an attempt to relate the present findings to those of 
previous workers. 
The Chapters are as follows: 
I. Bromide in the Blood. This deals with the bromide content in the 
blood of humans and guinea pigs, as well as bromide in human 
cerebrospinal fluid, its relationship to that in the blood and 
possible changes of these levels in disease. The relationship 
of bromide to the chloride content in these fluids is also 
considered. 
II. Bromide in the Tissues. The analysis of various tissues for 
bromide content with the aim to determine whether any particular 
organ or organs concentrate bromide as, for example, iodide in 
the thyroid or fluoride in bone. Also the general mode of 
variation of bromide accumulation in tissues. 
III.The Thyroid and Bromide. To study the possible effect of bromide 
on thyroid function, such as any interference with iodine 
metabolism. 
IV. The Excretion of Bromide. A study of the rate and manner of 
bromide excretion in humans, and its relationship to other 
electrolytes, particularly chloride. 
V. The Pharmacology and Toxicology of Bromide. Consideration is 
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given mainly to the effect of bromide administration to humans 
and animals in pharmacological doses. 
The chemical method for the estimation of bromide is 
initially described. 
6 . 
HUNTER' S METHOD - MICRO-DETERMINATION OF BROMIDE 
IN BODY FLUIDS (11, 12)  
This method was used for all chemical estimations of bromide 
in biological material during the present investigation. It is there-
fore described and discussed in detail. This micro-method for the 
estimation of bromide in the presence of chloride and in the absence 
of organic matter is based on the following reactions: 
(1) Bromide is quantitatively oxidised to bromate in a suitable 
buffered solution by hypochlorite: 
Br- + 3C10r 	Br03- + 3 Cl- 
(2) Bromate quantitatively gives six equivalents of bromine by reaction 
in acid solution with an excess of bromide: 
Br03- + 5 Br- + 6R+ 	3 Br2 + 3R20 
(3) Quantitative substitution of bromine in rosaniline decolourised by 
acid with the formation of a red solution (tetrabromorosaniline) 
which is measured colorimetric ally. 
The reaction (2) is carried out in the presence of rosaniline 
when the liberated bromine is found to react quantitatively. 
Reagents (all of AR quality unless stated otherwise): 
1. Sodium hypochloritd 1N in 0.1 N sodium hydroxide. 
The method of preparation is as follows: the bromine-free 
chlorine, which is generated by gently heating a mixture of hydrochloric 
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acid and manganese dioxide, is washed by passing through water and 
then into cooled 1.1 N sodium hydroxide solution. From time to time 
1 ml of this is removed into a small flask, 5 ml of 1% hydrogen 
peroxide is added to destroy the sodium hypochloride, and the solution 
is titrated with 0.1 N hydrochloric acid (using a suitable indicator) 
until the required 0.1 N NSCH concentration is obtained. 
2. Sodium formate, 50%1Vv. 
3. Buffer solution at pH 6.35 prepared by mixing 10 volumes of 401, 
V/v sodium dilaydrogen phosphate dihydrate (NaH 2PO4.. 2H20) 7 volumes 
of 2N potassium hydroxide and 5 volumes of water. 
4.. Rosaniline solution. Prepared by dissolving 6 mg of rosaniline 
in 100 ml of 2 N sulphuric acid. 
5. Bromide - molybdate mixture. By dissolving 0.14 g of potassium 
bromide and 3.0 g of anmonium molytdate in water and diluting to 100 ml. 
6. Sulphuric acid, 14N. 
7. tert.-Butanol containing 5% 7/7 of absolute ethanol. The ethanol 
is added to prevent freezing at roam temperature. 
PROCEDURE. 
(a) Preparation of the test solution. 
Place in a nickel crucible 1 to 2 ml (or less) of biological 
fluids (serum, C.S.F., urine), add a few drops 2 N - NaOH and dry at 
110°. Then ash at 600°C for 30 minutes in a muffle furnace. Remove 
the crucible and add 4 ml water. Stir with a glass rod and transfer 
the solution to a centrifuge tube and spin. Remove 3.5 ml of the 
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supernatant fluid into another test tube and add 1 ml buffer pH 6.35. 
Add 0.25 ml sodium hypochlorite solution, mix and heat for 10 min. in 
boiling water. Then add 0.25 ml sodium formate solution (to destroy 
the excess of hypochlorite), mix and heat for a further 5 minutes in 
boiling water. Remove, cool and add 0.2 ml water (the amount lost by 
evaporation). This is the test solution. 0 
(b) Colour reaction. 
In a test tube place 0.1 ml bromide - molybdate mixture, 
0.5 ml rosaniline solution, 0.4 ml 14N-H 2SO4. and 1 ml of the test 
solution. Mix and leave this reaction mixture for 3 minutes at 
20 - 30°C, then add 2 ml tert.-butanol and 1 ml 14N - H 2SO4. 
Mix the solution and measure the optical density in a 
suitable absorptiometer at about 570 imp. The action of tertsbutanol, 
a solvent, is necessary because the bromorosaniline is insoluble in the 
acid aqueous medium in which it is formed; tert.-butanol is convenient 
as this is mixable with the acid aqueous medium. 
If the test solution contains much more than 5jug Br - as 
- Br03 ' the colour of the final solution will be brownish owing to the 
destruction of the bromorosaniline formed by excess bromine. In such 
circumstances the amount of test solution should be reduced, but the 
volume should be kept constant by the addition of a corresponding amount 
of water before addition of the test solution. The amount of bromide 
present is readily calculable from the optical density reading, and the 
slope of the linear calibration curve for the absorptiometer used. 
During the present investigation this method was first carried 
9. 
out on NaBr and K Br solutions of varying concentrations from which a 
calibration graph was drawn up. This was done by dissolving varying 
amounts of K Br equivalent to 5, 10, 15, 20 and 25pg Br- per 4 ml of 
water, then taking off 3.5 of this and proceeding to make a test 
solution, from which 1 al was taken for the colour reaction. The 
optioal density thus obtained was plotted against the concentration to 
a maximum of 25 pig, after which concentration the calibration line 
ceased to be linear. That is, at this concentration (25 pg) each 1 ml 
of test solution contained 5 pg Br (as the total volume during the 
preparation of the test solution was 5 m1). In this way it was 
possible to read off the concentration up to 25 pg of the original 
biological material. Figure 1 shows this calibration graph. 
After this, two human sera were estimated and the wave-length 
of maximum absorption of tetrehromorosaniline was checked. As can be 
seen from Figure 2, both sera showed that the maximum absorption was at 
570 AP. 
A recovery experiment was also performed by adding known 
quantities of bromide (as NaBr) to the serum, mainly to test whether 
there is a significant loss of bromide associated with the destruction 
of organic matter during the ashing of serum. The tests were carried 
out in triplicate aml an average taken. The results are shown below. 
No. Serum Mg/ml 
Added 
jug Br/ml 
Expected 
jug Br/ml 
Found 
pg Br/ml Recovered.% 
1 9.3 3 12.3 12.0 97.6 
2 9.0 5 14.0 14.0 100 
3 5.0 5 10 9.5 95 
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No. Serum pg/ml 
Added 
pg Br/m1 
Expected 
pg Br/ml 
Found 
pg Br/ml Recovered% 
4- 8.4 5 13.4 11.0 82.1 
5 5.2 10 15.2 15.0 98.7 
6 . 8.0 10 18.0 16,2 90 
7 3.5 10 13.5 12.6 93.3 
8 7.5 10 17.5 15.0 85.7 
9 7.0 10 17.0 14.0 82.3 
10 6.5 10 16.5 16.7 101.2 
11 7.5 15 22.5 21.6 96 
12 12.0 15 27.0 25.7 95.2 
Hunter's method as described above, which was used for 
estimating bromide in biological fluids, was adapted in the present 
investigation to estimate the bromide content in various tissues, and 
proved to be quite successful. The main problem was to destroy most 
of the organic matter without a significant loss of bromide. Hunter 
suggested (12), as a means of destroying organic matter in the case of 
whole blood, to ash for 10 minutes in a furnace, cool and break down 
the charred mass with water, re-drying at 110°C, then re-igniting for 
20 minutes. However, during the present investigation it was found 
that if dried tissue is slowly ashed at 200 - 500 °C for approximately 
30 minutes, and then the temperature is increased slowly to 600 °C for 
another 50 minutes, this procedure destroys most organic material 
without any significant loss of bromide. 
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Hunter's method proved to be very useful for the estimation of 
relatively small quantities of bromide in biological material. Most 
of the tests were carried out in duplicate. A blank, which consisted 
of a few drops of 2 N NaOH in a crucible, which was then treated as other 
samples was included in every batch. The optical density of this was 
negligible in most cases. A control was also included in each batch; 
this consisted either of a solution of Nalr of known concentration, or 
a tested pooled serum. 
If the bromide level was found to be too high for accurate 
bromide estimation the test was repeated with water dilution, and here 
it was found to be important that the water should be added before the 
test solution, or the results obtained were too high. The colour was 
very stable, as in 24 hours the drop in optical density was almost 
negligible, and in 48 hours only slight. Bromine-free hypochlorite 
was absolutely essential, and had to be prepared in the laboratory, as 
the commercial reagent was employed on two occasions and proved to be 
quite unsatisfactory as it showed a high optical density for blanks and 
tests. 
Finally, it is important to note that only about 5jug of bromide 
in one test can be correctly estimated without dilution (i.e., 25 Ad 
specimen). If more bromide is present, the optical density decreases; 
e.g. 
Sample A - no dilution - 0.D. = .42 
1 : 5 - 0.1). = .45 
1 : 10 - 0.1). = .38 
The reason for this has been stated above. Generally, providing one is 
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aware of its limitations, this method has proved to be very useful and 
reasonably reliable. 
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CHAPTER I  
BROMIDE IN IHE BLOOD  
Damiens in 1921 (13) reported that cattle blood contains 
0.52 mg bromide/100 g fresh weight, while that of dogs varies from 
0.63 to 1.71 mg Br/100 ml. Bernhardt and Ucko in 1926 (14) found 
the blood bromide level for normal humans to be from 0.8 to 1,4 mg/ 
100 ml and in the serum from 1.0 to 1.6 mg Br/100 ml. Similar blood 
bromide levels were found by Roman in 1929 (15). Ueko in 1936 (16) 
analysed the blood from normal human subjects and found the bromide 
content in approximately 100 samples to be between 0.15 and 0.35 mg/ 
100 ml. Similar figures were found to apply to the blood of dogs. 
However, in a further 10 human subjects Ucko found that the range was 
from 0.6 to 3.0 mg/100 ml. He also found that the bromide/chloride 
ratio in the human blood was from 0.0005 - 0.0014, and claimed that 
about 1/5 of the total bromine is present in some organic complex. 
Evans (1955) (17) claimed that the normal bromide level in 
humans was from 0.5 to 2.0 mg/100 ml of serum, while Hunter (1955) (12) 
found the bromide values in human whole blood to be 1.20 to 1.32, in 
blood cells 1.40 to 0.92 and in plasma 1.43 to 1.42 mg Br/100 ml. 
Netelson et al. (1962) (18) reported the serum bromide level 
to range from 0.21 to 0.29 mg NeBr/100 ml, and Wikoff et al. (19) quoted 
a range from 0.1 to 3.3 mg NeBr/100 ml. 
Some of the reasons for the differences in the results of the 
above authors will be dealt with in the "Discussion". 
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The Bromide Distribution Ratio between the Blood Cells and Serum. 
(Q Br =Br concentration in red cells/Br concentration in serum.) 
It has been claimed by several investigators that bromide is 
selectively concentrated in the red blood corpuscles. Hastings and 
Win Dyke in 1931 (20) claimed that when bromide is added to blood in 
vitro, it is distributed in such a way that the distribution ratio of 
bromide between cells and serum (Q Br) is about lq% higher than the 
corresponding chloride ratio (Q C1), and they suggested therefore that 
the bromide replaces chloride from the blood cells. They further found 
that Q Br and Q Cl are lower in oxygenated blood than in reduced blood 
at the same pH, and increasing the pH of either oxygenated or reduced 
blood caused a decrease in both Q Br and Q Cl. In a subsequent paper 
(1931) (21) the same authors reported the results of their experiments 
in vivo. They claimed that when sodium bromide was administered to 
dogs by mouth, analysis of the blood revealed a much higher bromide and 
lower chloride concentration within the erythrocytes than would have 
been expected on the basis of the in vitro experiment. When a single 
dose of sodium bromide was given by mouth, the highest distribution 
ratio occurred 30 minutes after administration, then gradually decreased 
to the normal Q Br = 1.0 - 2.0 ratio. This ratio was constantly 
higher than Q Cl which was in the vicinity of 0.7. On the other hand, 
Q Br in vitro when NaBr was added, was never greater than unity. An 
attempt was made to determine the relative ease of diffusion of bromide 
from the cells of a bromide-fed dog into the serum of a normal dog and 
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conversely the ease of diffusion from the serum of a bromide fed dog 
into the cells of a normal dog. Blood samples were drawn from both 
animals and the bromide diffusion measured in vitro. 
After 10 minutes of equilibration Q Br in the blood composed 
of bromide-containing cells and bromide-free serum was 1.45, and the 
corresponding Q Cl was 0.5. After 2i hours equilibration Q Br had 
fallen to 1.09 and Q Cl had risen to 0.685. The Q Br and Q Cl of the 
blood composed of bromide-free cells and bromide-containing serum were 
respectively 0.84 and 0.66 after 10 minutes and 0.82 and 0.72 after 2i 
hours equilibration. The latter ratios were approximately those 
obtained in blood to whichbromide had been added in vitro, whereas the 
former ratios were much higher, and suggest a tendency on the part of 
cells from bromide-fed animals to retain their bromide. 
Hastings et al. (1932) (22) extended the investigation of the 
bromide cell - serum ratio (Q Br) to other mammals. They concluded 
from their studies that after intravenous injection of sodium chloride 
and sodium bromide into the animals, the red blood corpuscles have a 
stronger affinity for bromide ions than for chloride ions. The Q Br 
is generally greater and usually to the same extent as Q Cl. The 
presence of bromide lowers the chloride ratios even further. These 
findings were criticised by Palmer and Clarke (1933) (23) on the basis 
that the work of Hastings et al, covered a relatively short period of 
time after a high dosage of bromide, and that insufficient time elapsed 
for equilibrium to be established. They maintained that, given adequate 
time for equilibration, the blood cells do not preferentially take up 
bromide. 
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Mason (1936) (24) who in turn criticised the method by which 
Palmer and Clarke obtained their results investigated the distribution 
of bromide and chloride in chronically bromide-intoxicated humans and 
dogs. His findings showed that Q Br tended to be slightly greater than 
Q Cl. The difference was small and variable but was of the order 
reported for the in vitro system by 	and Van Dyke (20) (i.e. 
Mason found that with time these ratios tended to fall to average 
values of 0.75 for bromide and 0.67 for chloride). These are, however, 
in contrast to Q Br = 2.0 found by Hastings and Van Dyke in vivo. 
Ucko (1936) (16), on the other hand, failed to detect any 
selective concentration of bromide in the erythrocytes. He found that 
in humans the relative distribution of bromide between corpuscles and 
plasma was constant, whether it was present in normal or artificially 
increased amounts. Q Br was 0.33 and lower than was found for chloride. 
Weir and. Hastings (1939) (25) reported that, after the administration of 
sodium bromide to dogs by mouth or by intravenous injection, Q Br was 
higher than the corresponding Q Cl (i.e. Q Br "= 0.76 and Q Cl = 0.72). 
This therefore agreed with the observation made by Mason. 
Smith et al. (1941) (26) compared the bromide, iodide and 
chloride distributions between human red blood cells and serum, and 
found the Q Cl to be between 0.8 to 1.2; Q Br in comparison was clearly 
greater than unity, i.e. from 1.24 to 1.46, and this was attained in 10 
minutes and did not change even after three hours. Comparable results 
were obtained for Q I, which ranged from 1.20 to 1.36. These authors 
suggested that all three ions studied cross the red cell membrane at a 
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very rapid rate, since equilibrium is achieved in 10 minutes or less in 
each case. However, at equilibrium the cells contain a higher propor-
tion of bromide and iodide than does the serum. 
Mack and Shipley (1952) (27), using Br82 in rabbits and rats, 
found that the red cells contained approximately half as much bromide as 
plasma. Cole and Patrick (1958) (28) on the other hand. reported that, 
following an injection of Br82 into bromide deficient rats there was 
equal bromide distribution between the cells and plasma, with the ratio 
being maintained throughout the period of 1 to 96 hours. They claimed 
that there was initially a significantly higher concentration in the 
plasma. 
Hunter et al. (1954) (29) reported that, in humans, equilibra-
tion of bromide between plasma and corpuscles is established within five 
minutes of the addition of bromide in vitro and within 30 minutes in 
vivo. They have also shown that bromide ratios between blood, cells 
and plasma vary inversely as the pH, e.g.: 
PH 8 7.2 
Q Br in vitro 0.77 1.06 
Q Br in vivo 0.66 0.96 
Both of these findings are in accord with those of Hastings and Van Dyke 
(20). Hunter claimed that if the ratios are plotted against pH, they 
have about the same slope, with a shift of 0.3 pH unit causing a change 
of about lqg in the ratio. The chloride shift with pH has a similar 
magnitude (30). At normal blood pH the magnitude of the chloride ratio 
(Q Cl = Cl cita p) is close to 0.70 for man (31). 
18. 
As can be seen, there are conflicting reports on the 
distribution of bromide between the blood corpuscles and serum, ranging 
from the claim of significant concentration of bromide by blood cells, 
to slight concentration, to complete denial. Many factors are probably 
involved in these varying results, and some of these will be dealt with 
later in the "Discussion". 
Blood and Cerebro-Spinal Fluid. Bromide Ratio. 
Stern and Ganlier (1921) (32) demonstrated the presence of 
bromide in the cerebro-spinal fluid (C.S.F.) of animals at intervals of 
• 3, and 16 hours after intravenous administration of large doses of 
bromide. Walter (1925, 1929) (33, 34) measured the bromide distribution 
ratio between serum and C.S.F. in humans, and concluded that the ratio 
which 1' in the range of 2.90 to 3.30 was constant, and not influenced 
by time and the amount of bromide present. Mishkis et al. (1933) (35) 
reported this distribution ratio to be of the order of 1.5 to 2.0, and 
somewhat higher values from 2.4 to 2.8 were reported. by Malamund et al. 
(1934) (36). Hunter et al. (1954) (29) found in 30 humans ratio values 
from 2.6 to 3.10. They also showed that the ratio is independent of 
the level of bromide in blood, thus supporting the earlier findings of 
Walter. 
In considering these ratios there are several points stressed. 
by numerous investigators which should be borne in mind: 
(1) Methodology has to be considered as a factor in all cases 
where different authors appear to obtain divergent results. 
(2) The time allowed for equilibration of bromide between serum 
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and spinal fluid following the administration of bromide is important. 
Welter (30 recommended an interval of 	hours between the last oral 
dose of bromide and lumbar puncture. Wallace and. Brodie (1940) (37) 
found, after intravenous injection of sodium bromide to a dog, the Br 
serum/Br C.S.F. ratio to be nearly constant after seven hours, and 
constant from 24 hours to 13 days. Hunter et al. (29) showed on human 
subjects that 24 hours should be the minimal interval between intra-
venous bromide dosage and lumbar puncture, while a considerably longer 
interval of at least 24 hours is generally accepted. 
(3) Within the C.S.F., the bromide concentration decreases on 
ascending the neural axis. Thus Bau-Prussak (1927) (38) reported 
higher bromide values in the lumbar than in the cisternal fluids. 
Similar results were obtained by Masserman (1934) (39). Hunter et al. 
(29) found in "normal" humans that the bromide concentration of the 
ventricular fluid is about half that of the lumbar. The bromide level 
of cisternal fluid was found to be about midway between that of lumbar 
and ventricular fluid. It is clear, therefore, that values obtained 
will vary, depending on the position of puncture. Generally the 
lumbar C.S.F. is used for the estimation of serum/C.S.F. ratio. 
(4) The effect of repeated lumbar punctures on the bromide level 
in the C.S.F. has also to be considered. Walter (NO mentioned this 
point and Fleischacker and Scheiderer (40) reported a fall of 4,5 to 9% 
in withdrawing successively three 5 ml samples of lumbar fluid. Hunter 
et al. (29) also observed a similar effect. It is therefore important 
that when more than one sample of fluid is taken, the first drawn fluid 
should be used for the bromide analysis. 
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It could be concluded that, although the bromide serum/C.S.F. 
ratio is influenced by the above four points, on the whole all investi-
gators have found this ratio rather high in contrast with the values of 
0.89 to 0.99 obtained for chloride (24, 41). Although it is now 
recognised that C.S.F. is secreted and is not in equilibrium with serum, 
it is nevertheless interesting that the bromide ratio differs so greatly 
from that for chloride. 
Changes in Serum/C.S.F. Bromide Ratio. 
It has been suggested by Taylor and Hunter (1957) (42) that 
the two to three times higher concentration of bromide in serum as 
compared with cerebrospinal fluid is due to the active exclusion and/or 
excretion of bromide from the C.S.F. There have been several reports, 
however, indicating that this serum/C.S.F. bromide ratio is changed in 
certain diseased states: thus Mason (24) studied the serum/C.S.F. 
bromide and chloride ratios in four bromide intoxicated hospital patients. 
He found that the serum/C.S.F. ratio for bromide of 1.2-1.4 was higher 
than that for chloride. According to Mason, NaC1 therapy tends to 
increase this ratio and values as high as 4,5 were obtained during the 
period of salt therapy. Apparently in cases of prolonged intoxication, 
a larger proportion of bromide enters the spinal fluid than after a 
single dose or a brief period of bromide administration. The high 
ratios observed in the above mentioned patients during salt therapy 
point to the fact that bromide leaves the spinal fluid more rapidly than 
it leaves the serum. 
The serum/C.S.F. ratio has been reported to be disturbed 
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during the course of tuberculous meningitis also. Walter (34) noted 
changes in the "normal" distribution of bromide between the serum and 
the C.S.F. in a human case of tuberculous meningitis. More recently 
Taylor et al. (from Hunter's Department) (1954) (43) and Smith et al. 
(44) reported that the blood-C.S.F. barrier, to bromide is abolished, 
or profoundly depressed, during the course of tuberculous meningitis, 
and this barrier returns to normal when the infection is brought under 
control. Investigation on 33 patients with tuberculous meningitis 
revealed that in the majority of these oases the bromide serum/C.S.F. 
ratio was between 0.7 to 1.29 as compared with the normal of over 2.0. 
At the same time, the protein and cell content in the C.S.F. was 
increased. In other varieties of meningitis such a fall in the 
bromide serup/C.S.F. ratio proved to be exceptional, even though the 
changes in the amount of protein and the number of the cells were about 
the same as in tuberculous meningitis, and that on the whole, the blood-
C.S.F. barrier for bromide was very well maintained (43). 
Studies of the bromide ratio for ventricular (sly), 
cisterns]. (A/c), and lumbar C.S.F. (A/1) show that the relationship 
sly>. A/c%ipp. A/1 is invariable. In active tuberculous meningitis all 
three ratios are depressed, but their relationship is never reversed. 
It has been postulated by Hunter and his collaborators that 
the changes in the C.S.F. in tuberculous meningitis are the expression 
of spontaneous intratheoal tuberculin reactions, i.e. antibody-antigen 
response. This reaction may then inhibit active exclusion or excretion 
of bromide from the C.S.F. This hypothesis has been supported by the 
findings that the disturbance of the bromide serum/C.S.F. ratio in 
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tuberculous meningitis is identical with that of the experimental 
intrathecal tuberculin reaction. In these studies tuberculin has 
been introduced into the C.S.F. of experimental humans and animals 
with normal meninges. Tuberculin is a concentrated filtrate from 
the fluid medium on which the T.B. organism has been grown. It 
possesses antigenic properties but no infective property as it 
contains no living organisms. Injected tuberculin therefore will set 
up an antigen-antibody reaction without causing actual infection. 
This intrathecal tuberculin reaction is thus a true specific antigen 
antibody reaction which affects both the cellular and protein content 
of the C.S.F. This reaction had a great effect on the passage of 
bromide from blood to C.S.F. During the first phase of the reaction, 
the serum/C.S.F. bromide ratio falls to or below unity; in other 
words, the C.S.F. barrier to bromide is abolished. The ratio remains 
at this low level throughout the reaction, and then slowly begins to 
rise, but many weeks elapse before the barrier is completely re-
established. The rise of the C.S.F. bromide level is often, but not 
invariably associated with a rise of the C.S.F. protein level. At 
the beginning of the reaction the serum/C.S.F. bromide ratio falls as 
the C.S.F. protein rises, but the C.S.F. protein level returns to 
normal before the serum/C.S.F. bromide ratio (43). 
According to these investigators the serum/C.S.F. bromide 
ratio is a reliable indicator of the permeability of the blood-C. S.F. 
barrier to bromide, as is shown by the fact that it is independent of 
the absolute amounts-of bromide present in the blood and C.S.F. As 
it is difficult to diagnose the early stages of tuberculous meningitis, 
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they have suggested that the alteration in the serum/C.S.F. bromide 
ratio could. be  useful in the routine examination of suspected cases. 
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PRESENT INVESTIGATION 
AIMS. 
1. To estimate the serum bromide level in "normal" human subjects in 
order to establish the mean and range of serum bromide level in 
the local population (South Australia). 
2. To investigate whether there is any significant change in the 
serum bromide level in mental patients, particularly schizophrenics. 
This was done as the result of a claim of Zondek and. Bier (1932-33) 
(45, 46) that the normal bromide content of the blood and C.S.P. 
was greatly diminished during the different stages of maniac-
depressive psychoses. A second reason for this investigation was 
the known effect of bromide on the nervous system. 
3. To establish the serum bromide range in normal guinea pigs. This 
was important in view of the experimental work performed on the 
guinea pig during the present investigation. Some guinea pig as 
well as human sera were tested for organically bound bromine. 
4.. To calculate the red blood cells/Serum bromide ratio in humans and 
guinea pigs to find out the distribution of bromide between the 
blood cells and serum. 
5. To measure the blood-cerebrospinal fluid bromide ratio in some 
patients with suspected neurological conditions. 
METHODS AND RESULTS. 
(1) Blood for serum bromide estimation was obtained from known 
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"normal" human subjects, and from hospital patients with normal Na, 
and chloride levels. The bromide level was estimated by the chemical 
method in 96 human subjects. Most of the tests were carried out in 
duplicate. The results are shown in Table 1 and. Figure 3. From the 
results obtained, the mean (E4) and standard deviation (E( xn
- x)2) 
were calculated, and from these the range was established. The results 
of these calculations showed the mean as 9.3 and the standard deviation 
as 5.6, therefore the 91% range was 04c 9.34c 20.5. 
(2) The serum bromide level was estimated on 48 patients from a 
mental hospital, mainly schizophrenics. The results are shown below, 
and indicate that the serum bromide level in these patients mainly falls 
within the lower half of the normal range as established in experiment 1 
above. 
The results were as follows: 
pgBr/M1 serum Frequency pg Br/M1 serum Frequency 
2.5 1 7.0 2 
' 	3.0 3 8.0 2 
3.5 1 8.5 2 
4.0 21 9.0 3 
4.5 1 9.5 i 
5.0. 3 10.0 1 
6.0 . 4 10.5 1 
6.5 1 11.0 1 
TAME 1  
DISTRIBUTION OF SERUM BROMIDE LEVEL IN 96 HUMANS 
PE2trAll nc 
2.0 3 
3.0 3 
3.5 3 
4.0 
2 
5.0 5 
6.0 lo 
6.5 6 
7.0 7 
7.5 4 
8.0 4 
8.5 5 
9.0 8 
9.5 4 
10.0 4 
10.5 1. 
11.0 1 
12.0 3 
12.5 2 
14.0 3 
15.0 2 
16.0 1 
17.5 1 
18.0 2 
21.0 2 
23.0 2 
25.0 1 
30.0 2 
DISTRIBUTION OF SERUM BROMIDE LEVEL IN N HUMANS 	Fig. 3 
Asg—ml 
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(3) The bromide level was also estimated by chemical means in the 
sera of 18 normal guinea pigs. The values obtained ranged from 4.5 to 
11.0jug/ml. 
In order to determine whether there is any protein bound 
bromine in the serum, sera from 5 guinea pigs were precipitated with loy, 
trichloracetic acid, the precipitate was then washed 3 times with iso-
tonic glucose solution (5%) and the bromide was estimated in this washed 
precipitate. The result in all cases proved to be negative, indicating 
that there is no protein bound bromine in guinea pig sera. This has 
been confirmed by measuring the radioactivity (Br82) in the protein 
precipitate in two sera (after injecting Br82 into the animals) (see 
also Chapter on Tissues) which was practically negligible. Negative 
results were also obtained from the chemical bromide estimation of the 
serum precipitate from 10 human subjects. 
(4) The red blood cells/serum bromide ratio was calculated on 
blood samples from 10 "normal" humans. This was done by taking whole 
blood (sequestrin used as anticoagulant) and measuring the blood cell 
volume (haematocrit). The individual blood specimens were divided 
into two parts - one of these was spun off and the plasma removed. 
The bromide content was estimated in a given volume of whole blood and 
plasma. (It has been found that there is no difference between plasma 
and serum bromide content.) The ratio cells/Plasma was then calculated. 
The following results were obtained. 
No. of specimen Cell/plasma ratio No. of specimen Cell/Plasma ratio 
1 
2 
1.11 
0.66 
3 
4 
0.80 
0.98 
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No. of specimen Cell/plasma ratio No. of specimen Cell/Plasma ratio - 
5 1.01 8 0.53 
6 0.85 9 1.08 
7 0.76 10 1.18 
A similar procedure was adopted in measuring the bromide 
content in whole blood and plasma of guinea pigs and then calculating 
the cell/Plasma bromide ratio. In this case the estimation was 
performed on 3 animals, each of which had a high serum bromide content 
(i.e. the drinking water of these animals had contained 400 p.p.m. of 
bromide for a period of three months) as well as 6 normal guinea pigs. 
The cell/plasma bromide ratios were as follows: 
Animals with a hish plasma bromide level  
No. Plasma bromide level pg/m1 Cell/Plasma bromide ratio 
424 0.14 
324 0.70 
312 0.74 
Animals with a normal plasma bromide level 
No. Cell/Plasma bromide ratio 
1 1.70 
2 1.73 
3 0.54 
1.62 
5 0.93 
6 2.07 
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(5) The cerebro-spinal fluid protein, chloride and. bromide, as 
well as serum bromide contents were estimated on 24. human subjects with 
suspected neurological conditions. The serum/C.S.F. bromide ratio was 
then calculated. The results of these investigations are presented in 
Table 2. The bromide level in the C.S.F. of 11 human subjects was 
estimated in order to determine whether there is any relationship 
between the bromide level and the protein or chloride contents in these 
specimens of C.S.F. (see page 32). 
DISCUSSION.  
(1) A sample of 96 "normal" members of the population of South 
Australia had a 95% serum bromide .level range of 0 to 20.5 pg/ml. As - 
can be seen in Table 1 and. Figure 3, the greatest frequency of sera 
samples had values between 5 and 10 pg Br/M1, i.e. 59.% of the total 
specimens occurred in this 5-10pg:Br/M1 range. The effect of varying 
dietary intake may play a large part in the spread of the serum bromide 
levels in the above sample of the population. 
When the above results are compared with those obtained. by 
some other authors (see Table 3) the range of the bromide level in 
human serum is seen to be narrower, except in the case of Evans (17). 
Whether this is actually so, however, depends on the number of specimens 
examined, and it is not always clear how many specimens were tested by 
these various workers. On the whole, the values obtained by these 
workers are not very aifferent from those of the present investigation, 
with the exception of the results of Natelson et al. (18) whose figures 
TABLE 2 
INVESTIGATION OF SERUM C.S.F. BROMIDE RATIO IN INDIVIDUAL HUMANS  
Human Subject A B C D 
Sex Male Female Male Male 
Ate in years 38 48 75 66 
C.S.F. -Protein mg/100 ml 
(N = 10 - 40) 
60 55 70 36 
C.S.F. -Chloride 
m-equi7/litre 
(N = 120 - 130) 
132 125 118 125 
C.S.F. -Bromide 
Fg/al 3.1 5.2 2.5 2.5 
Serum-Bromide 
pg/ml 9.5 3.0 4.0 4.5 
Serum/C.S.F. 
Bromidv Ratio 3.06 0.58 1.60 1.80 
Diagnosis 
l 
Undiagnosed 
disease of 
nervous system 
Depression, 
alcoholism, 
Epilepsy 
Cerebral 
arterio- 
sclerosis, 
Epilepsy 
Under 
investigation 
TABLE 3 
BLOOD AND SERUM BROMIDE LEVELS OBTAINED IN HUMANS AND ANIMALS 
BY VARIOUS AUTHORS  
- 
Author Species Blood 4.18 Brim') Serum (pgBr/m1) 
Damiens (1920) Doge 6.3 - 17.1 - 
Bernhardt and. Ucko (1926) Humans 8.0 - 14.0 • 10.0 - 16.0 
Roman (1929) Humans 8.0 - 14,0 10.0 - 16,0 
Udko (1936) Humans 1.5 - 3.5 - 
Ucko (1936) Dogs 	• 	' 1.5 - 3.5 - 
Evans (1955) 	- Humans 5.0 - 20.0 
Hunter (1955) Humans 12,0 - 13.2 ' 14.2 - 
Natelson et al.(1962) Humans 	- 1.6 - 	2.3 
Present Investigation Humans 5.2 - 22.5 0 - 20.5 (average 11.0) 
n 	n Guinea-pigs 4,0 - 18.8 4.5 - 11 
■ a 
(average 	8.7) 
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are very low by comparison. Some of the probable reasons for the 
different serum bromide levels quoted by various authors are worthy 
of mention: the analytical method used; the dietary factors, and in 
addition it is not always clear whether the individual workers refer 
in their figures to bromide ions only, or to, for example, sodium 
bromide. In the present investigation figures always refer to bromide 
ions only. The bromide/chloride ratio in human serum was calculated 
to be on an average 0.0011 which is very similar to the figure obtained 
by Ucko (16). 
(2) The estimation of serum bromide levels performed on schizo-
phrenics was part of a wider investigation of different elements in the 
blood of these patients (47). 
These serum bromide levels were found to be, on the whole, 
well within the lower half of the normal range. In order to determine 
whether this finding had any connection with the disease or whether 
some other factor such as diet was involved in the low bromide levels, 
blood was taken from three distinct groups from the same mental 
hospital. These groups each consisted of 6 human subjects: (a) known 
schizophrenics, CO patients with other mental conditions, (c) staff 
members whose diets were similar to those of the patients. The results 
showed that the serum bromide levels in all three groups were similar, 
viz.: 
(a) schizophrenics 4. - 6 pg Br/ml, 
(b) non-schizophrenic patients 4. - 6.5 jag Br/ml, 
(c) staff 3- 6.5 pg Br/ml. 
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From the above figures the conclusion could be drawn that 
the dietary factor was the main cause for the relatively .low serum 
bromide levels in all patients listed previously, and not, as was 
suggested by Zondek and. Bier (45), due to the mental conditions of the 
patients. 
(3) The range of the serum bromide level of guinea pigs (4,5 - 
11.0).1g/m1) may not necessarily be much lower than that of humans, as 
only 18 guinea pigs were sampled, but all animals were living under the 
same conditions - dietary and otherwise. Therefore the dietary 
bromide intake was similar, and would have depended only upon the 
amount of food consumed by individual animals. This might explain 
the much narrower range as compared with humans. If, on the other 
- hand, the intake of Br was increased the serum bromide level rose 
correspondingly (see Chapter on Tissues, Table 9). The negative 
results obtained by testing the protein precipitate from serum of 
humans and guinea pigs is contrary to the findings of Ucko (16) who 
claimed that about one-fifth of the total bromine content in the blood 
is present in protein-bound form. 
(4) The red blood cells/serum bromide ratio of 10 human blood 
specimens was on the average 0.90 (range 0.53 - 1.18). This is in 
agreement with most other authors, with the exception of Smith et al. 
(26) and Ucko (16), whose results were higher and lower respectively 
..(see Table 4). 
The above ratio obtained in normal guinea pigs was higher 
than that of humans, with an average of 1.43 ( range 0.5 - 2.07). Only 
TABLE 4 
BLOOD RED CRUS/SERUM BROMIDE RATIO FOUND BY DIFFERENT AUTHORS  
Authors Species Bromide Ratio Cells/Serum 
Hastings and Van Dyke (1931) 
Mason (1936) 
Ueko (1936) 
Weir and Hastings (1939) 
Smith et al. (1941) 
Mack and Shipley (1952) 
Hunter (1954) 
Cole and Patrick (1958) 
Present investigation 
• 
Dogs -.  (administration, of Br) 
Humans and dogs (BF. intoxicated) 
Humans 
Dogs' 
Humans 
Rabbits and rats 
(using Br82) 
Humans 
Rata (using Br82 ) 
Humans 
Guinea pigs (normal) 
Guinea pigs (Bi. treated) 
- 2.0 
0.75 
0.33 
0.76 
1.24. - 1.46 
0.5 
0.96 
1,0 
0.53 - 1.18 
(average 0.90) 
0.5 - 2.07 
(average 1.43) 
0.14 - 0.74 (average 0.53) 
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one was well below unity, the other five were either near or well 
above unity. On the other hand, the guinea pigs with a high serum 
bromide level showed a much lower ratio (average 0.53), indicating 
that at a high blood bromide content a "saturation" point is reached, 
above which there is no increase of bromide content in the red blood 
cells. 
Although this cell/serum bromide ratio in humans obtained by 
different workers varies, the majority of these workers found the ratio 
to be close to or above unity, with the exception of ticko (16) and Mack 
and Shipley (27). 
The above ratio in guinea pigs was higher than that found by 
most workers for other animals, with the exception of Hastings and 
Van Dyke (20) whose figures are slightly above those of the present 
investigation. Generally this bromide ratio for both humans and 
animals was higher than the corresponding chloride ratio of 0.67 - 0.72 
found. by numerous workers (20, 21, 24., 25). 
There are several factors which could contribute to the 
varying results of the cell/serum bromide ratio obtained by different 
authors, but the most important of these is probably methodology. This 
includes not only the method of estimation of bromide, but also the 
general handling of specimens (e.g. pH change effect) and the red blood 
cells measurement, e.g. whether reliable haematocrits are performed, etc. 
(5) The serum/C.S.F. bromide ratio obtained in 3 cases was from 
1.6 to 3.0, and in a fourth 0.58. The three figures which are above 
unity agree with the findings of other workers for normal humans (see 
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Table 5). However, it is difficult to explain the ratio of 0.58, as 
other tests (e.g. C.S.F. protein content) and the final diagnosis did 
not suggest any significant change of permeability of the meninges. 
Unfortunately it was not possible to carry out the serum/C.S.F. Br" 
ratio on a proven case of tuberculous meningitis to determine whether 
this ratio drops, and rises after recovery, as claimed by Hunter (43). 
Although in the above experiment the protein content in the 
C.S.F. in three cases was above the normal range, there was no direct 
relationship between the bromide and protein levels in the C.S.F. 
This is confirmed by the results of measuring the relationship between 
the bromide and protein levels in 11 humans as seen in Table 6. 
Finally, the bromide/chloride ratio in the C.S.F. was 
calculated and found to be 0.00032, as compared with a corresponding 
ratio in the serum of 0.0011. 
TABLE 5  
SERUM/C.S.F. BROMIDE RATIOS OBTAINED IN HUMANS  
BY VARIOUS AUTHORS  
Author Species  
Serum/C.S.P. Bromide Ratio Physical Condition 
Walter (1925 and 1929) Human 2.90 - 3.30 Normal 
Mishkis (1932-33). Human 1.5 	- 2.0 Normal 
Melamund et al. (1934) Human 2.4 	- 2.8 Normal 
Hunter et al. (1954) Human 2.6 	- 3.1 Normal 
Mason (1936) Human 1.2 	- 1.4 Bromide intoxicated 
Taylor and Smith (1954) Human 0.7 	- 1.29 Tuberculous meningitis 
Present investigation Human 0.58 	- 3,06 Various diseases of the nervous 
system 
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CHAPTER II  
BROMIDE IN THE TISSUES  
Grange in 1851 (48) was probably the first to report the 
presence of bromide in animal tissues. He was followed by several 
other workers (49, 50, 51),. but their results were contrasting and any 
of the positive results reported have only qualitative values as the 
methods used were not very accurate. Damiens in 192Q (52) gave an 
extensive survey of the methods used by all these authors, and 
criticised them from the viewpoint of later techniques. In a subsequent 
paper (1921) (13) he provided the first accurate quantitative bromide 
figures in human and animal organs. He found that the amount of 
bromide is fairly constant in these organs, and reported the following 
findings; 
In the lungs, heart, liver, kidney and stomach of the chicken, 
the pheasant and the pigeon the bromide level ranged from 0.05 to 0.84 mg 
Br/100 g fresh weight. In the adrenals of cattle 0.13 and lung 0.42 mg 
Br/100 g fresh weight. 
Values in various organs of dogs ranged from 0.37 to 1.71 mg 
Br/100 g fresh weight. In the human liver, lunge and kidneys the range 
was from 0.14 to 0.25 mg Br/100 g fresh weight. He was unable to find 
a bromide content corresponding to the iodine content in the thyroid. 
The blood bromide level in the above animals and humans examined was 
slightly higher than in most tissues (see the figures in Chapter I). 
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Damiens also claimed that the content of bromide was greatly 
increased in the lungs of humans who had died from poisoning with gases 
containing bromide (13). His findings were extended by Bernhardt and 
Ucko in 1926 (14) who found the following values in dogs: 
Aorta, from 1.6 to 2.5; adrenals from 5.3 to 5.0; pituitary 
12.5 mg Br/100 g fresh weight. In humans they found the highest 
values in the pituitary gland, viz. from 15 to 20 mg Br/100 g fresh 
weight. This was followed by the aorta, from 2.0 to 2.5, the adrenals 
from 1.4 to 1.8. In the liver, spleen and thyroid the range was from 
0.6 to 1.4 mg Br/100 g fresh weight. They claimed, however, that the 
blood bromide level in humans is similar to that in the liver, spleen 
and thyroid, and considerably lower (about 20 times) than in the 
pituitary. 
Picussen and Roman in 1929 (53)  found the mean value of the 
bromide content of whole white mice to be 10.11 mg Br/100 g dry weight. 
Udko in 1936 (16) reported the bromide content in some tissues of the 
cow as follows: .thyroid 0.75 mg Br/100 g fresh weight, adrenals 0.62, 
pituitary 0.61, ovary 0.61. 
Perlman et al. (1941) (54), three hours after an injection 
of Br82 into rats, found the following content of radio-active bromine 
in the various tissues, expressed as the percentage of the administered 
. dose of Br 82/g: thyroid gg, liver, kidney, salivary glands and the 
. pituitary from 0.7 to 0.8,%, adrenals from 0.31 to 0.37%, brain from 
0.25 to 0.293, whole blood about 1.4. The latter contained the 
highest content of all tissues examined except the thyroid. They , 
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obtained similar results in guinea-pigs, when, two hours after 
injection of Br82 2 they recorded values in the thyroid from 0.52 to 
0.88%, whereas in the liver, the adrenal gland, and muscle, the concen-
tration did not exceed 0,32% of the administered dose ofBr82 . 
Baumann et al. (55) also found that in rats all tissues studied except 
the thyroid had a lower concentration of Br 82 than did the blood. The 
mean figures were: thyroid 0.99%, blood 0,67%, lutig 0.43, muscle 
0.07% of the administered dose of Br 82 . 
Cole and Patrick (28) measured the Br 82 uptake in bromide 
deficient rats and obtained the following results: intestine>kidney7. 
spleen )0 gonads ,P thyroid = adrenals'- pancreas> heart> liver> 
brain. 
Mack and Shipley (27) claimed that 24 hours after injecting 
Br82 (1.0mC4/kg body weight) into rats and rabbits, the greatest 
activity can be found in the serum then follows stomach .,,thyroid> 
gonadskidney-,pspleen>.pituitary,Psmall intestine>adrenals> 
liverl)Plarge intestine}brain ■jpmuscle. They suggested that the 
• relatively high values for stomach contents and stomach tissue might be 
explained on the basis of partial substitution ofbromide for chloride 
in the gastric juice. 113/ has been shown to behave similarly (56). 
Gamble et al. (57) have shown that the concentration of 
bromide in the gastric content is as much as four to six times as great 
as would be expected from the chloride content. This has been 
supported by Davenport and. Fisher (58) who claimed that gastric juice 
contains more bromide relative to chloride than does serum. The high 
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concentration of Br82 in the gastric content and. mucosa has also been 
demonstrated in experimental animals by Scieremark (59) and in man by 
Howe and Ekins (60) who showed that following the intravenous adminis-
tration of Br 82 an average of 2% of the administered dose was 
secreted into the stomach in 12 hours. The above results tend to 
confirm the early findings of Ucko (16) who claimed that in 10 "normal" 
humans, the content of bromide in the gastric juice of the fasting 
stomach is between 0.5 and 0.9 mg Br/100 ml and the Br/C1 ratio was 
between 0.0017 and 0.0055. The corresponding figures for blood were 
between 0.15 and 0.35 mg/100 ml and 0.0005 and 0.0014 respectively. 
Numerous experiments have shown that with a bromide intake 
over a long period, changes in the bromide content occur in the organs 
and blood. Winnek and Smith in 1937 (1) experimented on two groups 
of white rats, each group having a different amount of bromide in the 
diet. The results showed that the blood and all tissues of the rats 
on a low bromide diet contained much less of this element than the 
blood and tissues of the animals receiving larger amounts of bromide. 
The tissues examined gave no indication that any one organ retained 
bromide more tenaciously than the others. The highest level was found 
in the kidney, closely followed by the spleen, with about half that 
amount in the liver which was equal to the brain level. 
Neneki and Achoumow-Simanowski in 1894 (61) suggested that 
bromide displaces chloride in tissues. Several workers have shown 
since that when large doses of bromide are administered, the ratios of 
chloride to bromide are the same in the serum and in the tissues, with 
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the exception of the brain and the spinal fluid. This was confirmed 
by Weir in 1936 (62) who stated that bromide has no special affinity for 
any tissues and that the ratio bromide/chloride + bromide is constant 
in any animal for such diverse tissues as skeletal muscle, kidney, gut, 
skin, liver and blood. 
The results of Wallace and Brondie in 1939 (63) were in agree-
ment with Weir. They reported that in the tissues of dogs and cats 
bromide is distributed in the same ratio to chloride as in serum, 
presumably in proportion to the tissue extracellular fluid. In the 
brain however, this ratio was considerably less, which suggested a 
barrier to its free passage from serum to brain, e.g. the wet tissue/ 
serum ratio of bromide in the liver was 0.22, the brain cortex 0.12 and 
the cerebellum 0.22, whereas the corresponding figures for chloride 
were: liver 0.22, brain cortex 040 and cerebellum 0.52 respectively. 
The chloride concentration of the C.S.F. was found to be higher than 
that of the serum. They suggested that the fact that bromide and 
chloride are similarly distributed between the central nervous tissues 
and the C.S.F. involves ionic equilibrium between these tissues and the 
C.S.P. (63). 
These results and the conclusions drawn from them were 
supported by Weir and Hastings in 1939 ( 25) who found that after the 
oral administration of sodium bromide to dogs, none of the tissues 
examined could be regarded as having a special preferential affinity 
for bromide rather than chloride. The degree to which chloride was 
replaced by bromide was essentially the same in all the tissues and 
plasma studied, except the brain and the C.S.P. They concluded that 
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there is (a) no special affinity for bromide in the tissues, and (b) 
bromide diffuses freely into and from tissues where chloride is present 
until equilibrium is established. The percentage replacement in the 
brain and the C.S.F. was lower, however, than in the blood and otter 
tissues, and furthermore the replacement values in the brain and the 
C.S.F. agreed essentially with each other. They suggested therefore 
that the C.S.F. may be regarded as in equilibrium with the extra-
cellular fluid of the brain tissue, at least in so far as halide ions 
are concerned, and in this sense, C.S.F. may accordingly be considered 
representative of the extracellular fluid of the brain. 
Hellerstein et al. (1960) (60 examined the distribution of 
bromide in rat tissue at 6, 27 and 74 hour intervals after the intra-
peritoneal administration of sodium bromide. They analysed liver, 
muscle, skin and serum for bromide and chloride and found the ratio of 
chloride to bromide in the serum to be similar to the ratios of these' 
ions in the tissues examined which confirmed the findings of the early 
workers (57, 63, 65, 66, 67). 
There is evidence showing that when bromide is administered 
• in pharmacological doses, it moves into the interstitial fluid in 
equilibrium with plasma in the same way as chloride, except in the 
brain and spinal fluid where bromide/Chloride ratios are lower than in 
other organs (25, 63). In explaining the equilibrium between tissues 
in general and the serum, the assumption is made that the distribution 
of bromide in the tissues takes place in the extracellular water only; 
by analogy then, the corresponding extracellular water in the central 
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nervous tissues has the same relationship to the C.S.F. as that in 
other tissues has to serum (65). It is not surprising, therefore, 
that many workers (25, 66, 67, 68) recognised that bromide is not found 
in the brain in the same relation to chloride as it is found in the 
serum. It has been claimed (66) that the ratio of bromide of C.S.F. 
to that of serum is 0.75, while the corresponding ratio of chloride is 
1.20. In the case of the brain, equilibrium is established with the 
halides in the C.S.F. rather than with those in the serum. 
As has been mentioned, bromide and chloride are mainly 
distributed in the extracellular phase of tissue, and it therefore is 
necessary to define extracellular fluid: water makes up about 7q% of 
the weight of the adult human body. This water is distributed through-
out the body as intracellular and extracellular fluids. The intra-
cellular fluids amount to about 5q% of the body weight, while the 
extracellular fluids represent 20-2g%. Extracellular volume (E.V.) 
has been defined as the volume of fluid which surrounds and. bathes the 
cell (69). It can be visualised as including two major components: 
plasma water and interstitial water. Of the extracellular fluids, 
interstitial fluid amounts to about 10, of the body weight. The 
interstitial fluid may act as a fluid buffer between the plasma and the 
intracellular fluid for certain substances in certain tissues. Since 
plasma is subject to sudden variations in composition through absorption 
from the intestine, the imposition of interstitial fluid aids in main-
taining the more constant composition of intracellular fluid than would 
otherwise be the case. With this arrangement, the kidneys have the 
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opportunity to compensate for changes in the plasma before they are 
seriously reflected upon the intraoellular fluid. 
The moiety of fluid in the central nervous tissue (including 
the cerebrospinal fluid), the eye, the gastrointestinal tract, the 
pericardial space, pleural space and joints has been called trans-
cellular fluid, and this fluid is part of the extracellular phase; 
this is, however, only a very small percentage of the whole of the 
extracellular volume. 
The extracellular fluid is very commonly divided in the 
literature into two main components, viz, the intravascular fluid 
(mainly plasma) and extravascular fluid (mainly interstitial fluid) 
and on this basis some authors speak of the ratio between tissues and 
plasma. This differing interpretation should be borne in mind. when 
discussing the ratio between tissues/Plasma or tissues/C.S.F. 
Some ions such as potassium are found mainly in the intra-
cellular fluid; on the other hand, many investigators have concluded 
from tissue analysis that chloride is predominantly, though not 
exclusively, extracellular (69, 70, 71, 72, 73, 74., 75). 
Gotlove (76) infused insulin and sucrose into rats constantly 
for a prolonged period with subsequent analysis of the muscle for 
saccharide content to study the position of chloride in muscle tissue. 
These sacoharides did not penetrate the tissue cells. He found that 
the saccharide and chloride spaces of the muscle were equal; in other 
words, no chloride was found within the muscle cell. Cheek et al. (77) 
extended this study to the viscera and found that the inulin space in 
the viscera was almost equal to the chloride space. In the studies on 
rats (77) it was found that 9q% of total body chloride was extra-
cellular, while the majority of non-extracellular chloride was present 
in the red blood cells (6g) or in the visceral cells (14). Edelman 
and Liebman (78) concluded that 12.4 of chloride is extracellular in 
man, therefore the correction of the chloride space in the whole body 
by a factor of la% is normally considered to approximate the true 
extracellular volume. 
This chloride space is frequently measured with substances 
that follow the distribution of chloride in the body very closely. 
Wallace and Brovidie (63) compared tissue bromide/serum bromide and 
tissue chloride/serum chloride and concluded that the distribution of 
both halides was similar in all tissues examined except the brain. 
Similar results were obtained by Weir and Hastings (25) who found that 
there was agreement between the amounts of extracellular fluid per kilo 
of tissue calculated, on the one hand from chloride data and on the 
other from bromide data. Manery (75) showed that the volume of dis-
tribution of bromide in muscle closely approximates the chloride space 
of muscle. In general, it can be said that bromide and chloride 
distribute in a similar manner in all tissues (25, 57, 65, 66, 79) with 
the exception of the central nervous system, and possibly of the 
thyroid and the red blood cells (see Chapter I). 
It is now generally accepted that administered bromide 
distributes itself principally, if not entirely, throughout the extra-
cellular phases in tissue. Accordingly, bromide is frequently used 
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for the determination of total extracellular fluids. For this purpose 
, the most useful form is radioactive bromide Br 82  1/433-37). It has 
certain advantages, viz, only small amounts are needed for injection, 
• bromide is not metabolised in the body, and it is excreted slowly. 
Fink and Cheek (80) reported that isotopes of chloride and 
bromide are of equal value in the determination of the corrected 
chloride spaces. A correction factor of 10% is applied to the bromide 
or chloride space to allow for intracellular chloride and bromide. In 
adult-life the corrected bromide space-water is equal to about 20-2* 
of body weight (65). 
Considering that bromide is mainly distributed in extra-
cellular fluid, it can be concluded that in the event that the tissue/ 
plasma ratio of bromide for any particalar tissue exceeds unity, 
conclusive evidence would be at hand that the cells of that tissue are 
able to concentrate bromide ions. If the cells of a particular tissue 
do not take up bromide ions, then the concentration of bromide ions in 
that tissue will depend on the amount of interstitial fluid and the 
vascularity of the tissue. 
It has been shown that the majority of investigators in this 
field failed to produce evidence that any organ can selectively 
concentrate bromide ions. The thyroid may be an exception, as several 
workers found a higher concentration of bromide here than in the serum, 
but this appeared to depend on the iodine stores of the body (see 
Chapter on the Thyroid). Some of the early workers reported a high 
concentration of bromide in the pituitary. As mentioned above, 
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Bernhardt and Uoko in 1926 (14) found a very high concentration of 
bromide in the pituitaries of clop. This has been supported by Zondek 
and Bier in 1932-33 (45, 46) who reported that, in dogs, the hypo-
physeal bromide diminished or disappeared during artificial sleep, 
whereas the bromide content of the mesencephalon increased. The 
authors suggested that the pituitary secreted a substance containing 
bromide which could act upon the cerebral centre producing sleep. The 
report suggested a physiological action of bromide; the work has, 
however, been repeated by other investigators and although some have 
substantiated it (81) others have been unable to confirm the results. 
Dixon (1935) (82) and Ucko (1936) Using newer analytical 
methods failed to find the existence of any preferential concentration 
of bromide in the hypophysis of ox, pig or man. 
Perlman et al. (1941) (54) using radioactive bromide could 
not demonstrate a high concentration of radiobromide in the pituitaries 
of rats. 
Mack and Shipley in 1952 (27) reported the results of their 
experiment on the distribution of Br 82 in various tissues of rabbits 
and rats. They confirmed the findings of Perlman et al., and found 
that the tissue/serum ratio of bromide in the pituitary of rabbits was 
0,28, while that of rats WEIS 0.36. These figures contrast sharply 
with the ratio of 17-20 obtained by the early workers, and it would 
appear that the reliability of the early methods used is open to 
question. 
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PRESENT INVESTIGATION 
AIMS. 
(a)The Distribution of Bromide in the Various Tissues. 
Although other workers have investigated the bromide content 
in the tissues of a number of animals, the analysis of guinea-pig 
tissues has been relatively neglected. Radio-isotopic and Hunter's 
chemical methods were used to estimate bromide distribution in guinea - 
pigs, and to determine whether any tissue selectively concentrates 
bromide. 
Bromide levels in the tissues of the human, the rat and the 
rabbit were also studied and. compared. 
(b) The Pattern of Accumulation of Bromide. 
It is known that when bromide is administered_ in pharma-
cological doses, it accumulates almost entirely in the tissue fluid 
spaces. This experimental work, however, is aimed at determining 
firstly whether all tissues take up bromide to the same extent, and 
secondly whether the tissue/Serum ratio is less than unity in each 
individual tissue, as is the case in normal untreated animals. The 
results of these assays would indicate whether the prolonged adminis-
tration of high doses of bromide alters the tissue/serum ratio of 
bromide. 
(0) The Effect of Fluoride on the normal Bromide Level. 
It has been stated in the previous pages that bromide can 
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replace chloride in the tissues and. blood. The question then arises 
whether the normal bromide content in the tissues can be similarly 
replaced by other halides. This experiment was set up to ascertain 
whether fluoride ions affect the bromide level in the tissues and serum 
of guinea-pigs. 
(d) Bromide in the Pituitary and. Brain. 
This experiment was carried out to investigate the claim of 
Zondek and. Bier (45, 46) concerning the high bromide content in the 
pituitary and its possible physiological function. If their findings 
were correct, one would expect to find a relatively high concentration 
of bromide in the pituitary, most of it being organically bound, and 
possibly a relatively higher concentration of bromide in some parts of 
the brain. If the pituitary gland does in fact selectively accumulate 
bromide this would be of considerable interest, because of the implica- 
tion that bromine may participate in the synthesis of pituitary hormones. 
METHODS AND RESULTS. 
(a) Bromide Distribution in Tissue. 
(1) Radio-active bromine method: 
An activity of 10,pCi of Br 82 was injected into the peritoneal 
cavity of each of six guinea-pigs. After 2/4- hours the animals were 
anaesthetised and blood was taken by heart puncture. The animals were 
then dissected and the activity of the various organs and tissues was 
measured using a whole body monitor. The resulting grades of activity 
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are shown in Table 7. 
(2) Chemical method: 
15 adult guinea-pigs of both sexes were used. The animals 
were anaesthetised, blood was taken by heart puncture for further 
investigation, and they were then dissected. Various tissues and 
sera were analysed for bromide content. Rabbits and rats were treated 
in the same manner, and human organs were obtained following post mortem 
examination, and similarly studied. 
The results of these analyses are shown in Table 8. 
(b) The Pattern of Accumulation of Bromide. 
Guinea-pigs were divided into eight groups with 2 to 8 animals 
in each group; varying amounts of bromide OK Br and Na Br) from 10 
p.p.m. to 400 p.p.m. were added to the drinking water of each group. 
A control group was given distilled water, while food was common to all 
groups. The animals were kept in this condition for two months, after 
which they were anaesthetised, blood was taken by heart puncture, and 
they were dissected, and lung, kidney, heart, liver, brain, muscle and 
serum were analysed for bromide content (see Table 9). 
(c) The Effect of Fluoride on Normal Bromide Level. 
Three guinea-pigs were kept for 5 weeks and 5 p.p.m. of 
fluoride (Na F) was added to their drinking water. A control group was 
also run at the same time. The animals were then killed and 
dissected, and the bromide levels were measured in the lung, kidney, 
heart, liver, brain, muscle and serum. 	The 
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resulting figures are shown in Table 10. 
(d) Bromide in the Human Pituitary and Brain. 
(1) Using the chemical method, the bromide level in several 
pooled human pituitaries was estimated. The glands were collected 
over aTeriod of 7 days following post mortem examination. The 
resultant level of bromide found, as seen in Table 8, is not high 
compared with that of other tissues. 
(2) Homogenate was obtained from about 150 human pituitaries and 
this was dialysed against distilled water, which waa repeatedly tested 
for bromide until no bromide was detected.. The homogenate itself was 
then tested for bromide, and the result was negative. 
(3) A human brain was dissected into the major parts, and 
samples of tissue from these various regions were analysed:for bromide. 
The result of these findings is shown in Table 11. 
DISCUSSION. 
(a) Distribution of Bromide in Tissues. 
In considering the uptake of Br 82 by various tissues in 
guinea pigs it must be stated at the outset that for technical reasons 
not all the tissues listed were examined in each guinea pig. It is 
therefore possible that, had more specimens been measured, the average 
figures in some instances might have been different. Secondly, there 
was a considerable variation in the uptake of Br 82 by the same tissue 
in different animals (see Table 7). 
TABLE 7 
Br82 UPTAKE BY VARIOUS TISSUES IN GUINEA-PIGS  
Tissue 
p Ciii g wet tissue 
• in individual gainea-pigs - Average mlp Ci/g tissue 1 2 3 4. 5 6 
Pancreas - .0246 - .0121 - - 18.35 
Thyroid .0166 .0250 .0200 .0139 .0115 - 17.40 
Lung .0190 .0154 .0147 .0152 .0159 .0159 16.01 
Kidney .0162 .0132 .0122 .0117 .0141 .0072 12.43 
Heart .0100 .0109 .0091 .0109 .0089 .0096 9.90 
Gonads - .0088 .0087 .0097 .0114 .0106 9.84. 
Spleen .0099 .0104 .0081 .0093 .0104 - 9.62 
Liver - .0092 .0080 .0078 .0085 .0084 8.38 
Diaphragm, .0016 - .0019 .0082 .0016 8.32 
Adrenals .0069 .0076 .0092 .0073 .0071 7.62 
Bone .0071 - .0057 _ 6.40 
Skin .0059 - _ .0045 5.20 
Brain - .0052 :0050 .0034 .0054 4.75 
Muscle .0041 .0042 .0037 .0046 .0043 4.18 
Fat - - .0024 .0024 2.40 
Serum (1 ml)  .0260 .0259 25.95 
Whole blood .0230 .0220 22.50 (1 ml) • 
TABLE 8 
BROMIDE IN TISSUES  
• (ug/1 g wet weight) 
Tissue Guinea-pig Man Rabbit 
, Rat 
Stomach 
, 
12.6 - 17.2 
*(4.) 
- - - 
Lung 410 - 10.4 
12) 
4,7 - 12.0 
(7) 
3.2 - 7.0 (2) 5.2 - 8.8 (9) 
Kidney 4,5 - 7.0 
(11 ) 
4,1 - 8.2 
(7) 
3.2 - 8.0 
(4.) 
4.3 - 4,5 
(2) 
Heart 4,4 - 7.0 
(9) 
3.0 - 9.0 
(7) 
3.5 - 4.0 
(3) 
3.0 - 4,0 
(8) 
Liver 3.2 - 6.6 
(13) 
1.8 - 5.5 
(12) 
1.0 - 3.6 
(7) 
1.8 - 2.9 
(8 ) 
Spleen 3.4 - 6.1 
(8 ) 
5.0 - 10.0 
(8)  
- 3.2 
(7) ** 
Brain .8 2.5625 1.6 
(1) 
3.0 
(2) 
2.2 - 2.5 
(2) 
Muscle 2.6 - 5.2 
(11) 
- 1.0 (1) 
1.2 - 2.2 
(9) 
Adrenals 3.3 
(6) 
Thyroid 
ep 
- 4,5 - 5.2 
(3) 
- _ 
Pituitary 5.2 (7)" 
Gonads - - - 3.5 (1) 
Prostate 3.2 
(1) 
Serum 
pl; Br/M1 
. 
4,5 - 11.0 
(18) 
A 
0 - 20.5 
(96) 
A . 
* Figures in brackets represent number of specimens. 
** Pooled specimens. 
TABLE 9  
CUMULATIVE EFFECT OF BROMIDE FEEDING 
(2-8 guinea-pigs in each grOUP) 
ppm Br in 
drinking 
water 
Thyroid Lung Kidney Heart 	Liver 
(gig Br/1 g w.w.) 
Brain Muscle Serum 
(pg Br/ml) 
Normals *7.0 5.9 5.9 5.5 4.0 3.5 7.7 
10 	. 21 19 16 16 16 13 27 
15 28 29 23 14 - 23 35 
20 38 32 32 29 28 36 42 
30 40 4.2 38 4.9 38 73 
80 50 54. 49 4-9 43 42 - 
200 107 137 131 86 72 66 206 
300 145 14-6 147 150 112 88 305 
4.00 200 169 160 171 164. 14.0 102 380 
. .. 
* All figures are calculated averages. 
TABLE 10 
THE INFLUENCE OF FLUORIDE FEEDING ON BROMIDE DISTRIBUTION  
'IN GUINEA PIGS  
-Normals 	. 5 ppm of Na F in drinking water for about 5 weeks 
Organ No. of specimens 
Range 
(lig Br/1 g w.w.) 
No. of 
specimens 
Range 
(pg Br/1 g w.w.) 
Lung 12 3.7 - io.4. 3 2,2 - 2.6 
Kidney 11 4.5 .. 7.0 3 1.8 - 2.1 
Heart 9 4.4 - 7.0 2 2.3 - 2.5 	' 
Liver 12 3.2 - 6.6 3 1.9 - 2.2 
Brain 12 2.5 - 5.8 3 1,0 - 1.3 
Muscle 11 2.6 - 	5,2 3 1.0 - 1,2 
(pg Br/ml) (pg Br/ml) 
Serum 18 4.5 - 11.0 5.0 - 6.0 
■ 	- . A a 
TABLE 11  
BROMIDE IN HUMAN BRAIN 
No. Region of Brain Examined. p.gBr/g wet wt. 
1. Craaal Nerves 1.8 
Cerebellum: 
2. Tonsil, Flocculus, Inf. Vermis, etc. 1.9 
3. Peduncles 0.9 
4, Cortex 1.9 
5. Medulla 1.3 
Midhrain: 
6. Brachia, Tectum, Pineal Colliculi and Deeper Tracts 1.5 
7. Substantia Nigra and. Red. Nucleus 1.8 
Pons: 
8. Anterior 	V 1.3 
9. Post. - Tracts 1.3 
10. Medulla Oblongata 0.9 
Cerebrum: 
11. Visual Cortex 1.8 
12. Auditory Cortex 1.9 
13. Frontal Cortex 1.5 
14. Motor and Pre-Motor Area 1.9 
15. Sensory and Pre-Sensory Area 1.8 
16, Fimbria, Dentate Gyrus, Uncus Hippocampal Gyrus 1.3 
17. Insula 2.4 
18. Other Cortex Mole Areas) 2.0 
19. Corpus Callosum, Fornix and Cingulum 1.8 
20. Forceps, Tapetum and Corona Radiatum 1.3 
21. Basal Nuclei 1.9 
22. V 	Association Fibres, Commissural, Projection 1.1 
a 4 
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Bearing in mind the above, it was found that 3 or 4. tissues 
- had a relatively high Br82 uptake, viz, pancreas, thyroid, lung and 
kidney, whereas low uptakes were seen in skin, brain, muscle and fat. 
The remaining tissues examined all showed an uptake similar to each 
other between these two extremes. One point of interest is that the 
bromine uptake of bone was higher than that of either brain or muscle 
tissue. 
Although the highest average uptake was in the pancreas, only 
two specimens of this organ were measured; one was relatively high, and 
the other much lower. However, in 2 cases where . Br82 uptake was 
measured in both pancreas and thyroid, it was found that Br 82 Uptake by 
the thyroid was consistently higher than by the pancreas (see Table 7). 
Generally, the uptake by the thyroids was variable in individual guinea 
pigs and ranged from 25.0 to 11.5 m7mCi/g tissue. On the other hand, 
the uptake of the lungs was almost uniform in all animals. The 
variation in the thyroid uptake could have been due to the individual 
variation of the guinea pigs or to the relative iodide level in the 
body (see Chapter on the Thyroid). Further, an examination of the 
results of this experiment indicates that the uptake by the liver is 
approximately half that of the lung. 
Finally, it could be stated that, although there is a definite 
difference in the degree to which various organs take up bromide (Br 82), 
even those tissues with the highest uptakes do not exceed that of blood, 
i.e. the tissue/Plasma ratio does not exceed unity, although it is 
possible that the thyroids in some animals might have achieved unity. 
Unfortunately, it was not possible to measure the blood and serum from 
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all animals. 
In comparing the above results with those of other authors 
(see Table 12) it would appear that, although different workers found 
significant variations in the uptake of Br82 , there are certain common 
features to all. For example, all workers found in all species the 
lowest Br82 uptake to be in brain and muscle, while, with the exception 
of Cole and Petrick (28), the thyroid, stomach and spleen were the 
tissues with the highest uptake. That of the adrenals was very similar 
in most cases, and while Perlman et al. (50 and Baumann et al. (55)
•found that the Br82 uptake of the thyroid was greater than that of 
serum, Mack and Shipley (27) found the reverse to be the case. 
Despite certain variations (e.g. Cole and Patriak's 
pancreatic findings) a similar general pattern of Br 82  uptake in the 
tissues was found by the previous workers and in the present 
investigation. 
The bromide levels in the various tissues of normal guinea 
pigs which were estimated by chemical means slum variations in 
individual animals (see Table 8). Although fewer tissues were 
examined compared with the Br82 uptake method, a similar pattern can be 
seen, viz, lung, kidney and heart with a relatively higher bromide 
content than liver, brain and muscle. However, in this experiment the 
stomach was also examined and was found to have by far the highest 
bromide content, and was in fact the only tissue in which the tissue/ 
serum ratio exceeded unity. This supports the findings of Mack and 
Shipley (27), Gamble et al. (57) and others that the stomach concen-
trates more bromide than any other tissue. 
TABLE 12  
Br82 UPTAKE IN VARYING AMOUNTS CARRIED OUT BY DIFFERENT AUTHORS  
Author 
. 
Species Tissue 
. 
Perlman et al. (1914) Rats Thyroid > whole blood 7 liver = 
kidney = salivary gland = 
pituitary 7 adrenals -7 brain. 
Mack and. Shepley (1952) Rats and Serum 7 stomach -7 thyroid 7gonads"7 
rabbits kidney 7 spleen 7pituitary > 
small intestine 7 adrenals > 
liver 7 large intestine >brain 7 
muscle. 
_ 
Baumann et al. (1956) Rats Thyroid. 7 blood. 7 lung 7 muscle 
Cole and. Patrick (1958) Rats Intestine 7 kidney 7 spleen > gonads 
> thyroid. = adrenals >pancreas 7 
heart 7 liver 7 brain. 
Present investigation Guinea Serum -7 pancreas 7 thyroid 7 lung > 
pigs kidney 7 heart 7 gonads 7 spleen 
7 liver 7 diaphragm 7 adrenals 7 
bone > akin > brain >muscle >- 
rat. 
- . 
5 . 
In comparing the results of different authors of the bromide 
content in various tissues of several species, two main factors must 
be kept in mind: firstly, the different chemical methods of bromide 
estimation in biological material, and secondly, the variation due to 
different dietary habits. Table 13 shows the values obtained by 
different workers, and the following observations could be made: 
the results obtained. by Damiens are very similar to those of the 
present investigation except in the human, where the findings were 
somewhat lower. On the other hand, by comparison the results of 
Bernhardt and Ucko are high, particularly for the pituitary; this 
could have been due to the analytical method used or toestimating the 
bromide content of tissue from animals with some degree of bromide 
intoxication, or a combination of both factors. However, the 
difference in the findings between the liver and spleen on one hand 
and the pituitary on the other is very hard to explain if the same 
animals were used for both, but this is not known. 
Although Picussen and Roman (53) obtained 25 4pgBr/g wet 
weight in whole white mice, this figure may not be unusually high, as 
the bromide estimation in whole animals includes organs with a very 
high bromide content such as the stomach and its contents, while the 
diet may also have been a contributory factor. The results obtained 
by Ucko (16) in the tissues of the cow are within the range obtained in 
the present investigation, in which Hunter's method has been used. 
The cumulative effect of bromide intake shows that the level 
of bromide in the tissues and serum is dependent on the bromide content 
of the diet. Taking into account the individual variation of the 
TABLE 13, 
pg OF BROICIDE/g WET TISSUE. DERIVED FROM THE LITEMANURE 
• 	Author Species Tissues 
Adrenals Heart Kidney Stomach Lung Liver Spleen Thyroid Gonads Pituitar3 
Wmiens (1920) Chicken, Pheasant, Pigeon (Range from 0.5 to 8.4) 
Cattle 1.3 4,2 
Human 1.4, 2.5 (1.4- - 2.5) 
ernb.ardt and Uoko (1926) Dog 50 125 Human 14,-18 (6.0 - 14,0) 150-200 
'icussen and. Roman (1929) Mice Content of whole white mice 25 
. pgig w,w. 1 
reko (1936) Cow 6.2 7.5 6.1 6.1 
'resent Investigation Guinea- 
pigs 3.3 . 4,4, 7.0 
4.5- 
7.0 
12.6- 
17.1 
4,0-10.4 3.2- 
6.6 
3.4- 
6.1 
Human 3.0- 
9.0 
4,1- 
8.2 
- 4,7-12.0 1.8- 
5.5 
5.0- 
10.0 
4,5- 
5.2 
- 5.2 
Rabbit - 3.5- 
4,0 
3.2- 
8.0 
- 3.2-7.0 1.0- 
3.6 
- - - 
Rat - 3.0- 
4,0 
4,3- 
4,5 
- 5.2-8.8 1.8- 
. 2.9 
3.2 ' - 3.5 - 
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animals, examination of the results shown in Table 9 reveals a certain 
pattern of this cumulative effect. Firstly, in almost all tissues the 
increase in the bromide level was roughly proportional to the dose 
given, although in the lung, kidney and heart the large doses (viz. 500 
to 400 p.p.m.) did not give rise to a corresponding increase of the 
bromide level in these tissues. Secondly, at the high bromide doses 
the differences between the bromide levels in the tissues tended to 
decrease, with the exceptions of muscle and, to a lesser extent, brain. 
Thirdly, at the high doses where the thyroid content was also measured 
this tissue proved to have a far higher bromide content than any other 
tissue examined. Finally, none of the tissues examined showed a 
greater bromide content than serum, and the tissue/serum ratio did not 
exceed unity. Generally, this ratio decreased with increased dosage 
of bromide in all tissues (see Table 14), and although at 400 p.p.m. the 
ratio in the thyroid was highest compared with other tissues, it was 
nevertheless well below unity. 
It can be concluded from this experiment that the prolonged 
administration of high doses of bromide alters the tissue/serum ratio 
by lowering it. 
The figures in Table 10 show that fluoride affected the 
distribution of bromide in the tissues of guinea pigs. In the tissues 
examined the level of bromide in tissues of animals which were on 
fluoride was significantly lower compared with untreated animals. To 
prevent any inter-batch difference during the chemical estimation, 
though this has been found to be small when it does occur, controls and 
TABLE 14 
SEE EFFECT OF  INCREASING DOSES OF BBOIIIDE ON BIB 
TISSUE/SMRIA1 !AMIDE RATIO  
ppm Br 
in drinking 
water 
Thyroid. Lung Kidney Heart Liver Brain Muscle 
Formal 0,90 0.77 0.77 0.71 0.52 0,45 
10 0,78 0.70 0.59 0.59 0.59 0,48 
15 0,80 0.83 0.66 0.40 - 0.66 
20 0.90 0.76 0.76 0.69 0.67 0.86 
30 0.55 0.58 0.52 0.67 - 0.52 
80 - - - - - - 
200 0,52 0,67 0.64. 0.42 0.35 0.32 
300 0.48 0.48 0.48 0.49 0.37 0.29 
400 0.53 0.44 0.42 0.45 0.43 0.37 0.27 
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fluoride animals were tested in the same batch on three occasions. 
The significance of the differences obtained between control and 
fluoride animals may not be as great as it appears, since only 3 
animals on fluoride were tested. Nevertheless, the findings merit 
attention. 
Examination of the bromide level in 7 human pituitaries 
showed that the bromide content was not higher than in other tissue 
(see Table 8). Extensive dialysis of homogenate of human pituitaries 
and the subsequent testing of the homogenate for bromide indicated 
that bromine is unlikely to be bound to a protein or any undialysable 
organic molecule. It does not, however, exclude the possibility of a 
small dialysable organic molecul • Nevertheless, the relatively low 
bromide content in the pituitary would tend to reject this possibility 
because it mould be expected that if a particular organ concentrates 
bromide, and therefore has a tissue/serum ratio well above unity, this 
would probably require some bromide binding within the cells. Since 
the bromide level in the pituitary was low, such organically bound 
bromine is therefore unlikely. In addition, the bromide estimation of 
various parts of a human brain showed (see Table 11) not only that the 
bromide level in the brain is very low, but also that there is no sig-
nificant difference in the bromide level between the various parts of 
this organ. 
In conclusion, it must be stated that the present investiga-
tion gave no evidence to support the claim of Zondek and. Bier (45, 46) 
concerning the possible physiological function of bromide in the 
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pituitary and brain. The tissue/serum ratio of bromide in the human 
pituitary was calculated and found to be 0.50, a somewhat higher figure 
than Mack and Shipley (27) reported for the rabbit and rat. 
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CHAPTER III  
THE THYROID AND BROMIDE 
The thyroid gland has the capacity for concentrating iodine 
and maintaining a concentration gradient of 25 - 500 times that of the 
serum under various conditions (83, 84). The fact that almost all of 
the iodine in the normal gland is organically bound (85) might suggest 
that this concentrating capacity is mainly dependent upon the gland!s 
ability to convert inorganic iodide to ditodotyrosine and thyroxin. 
Although this view is supported by the rapid rate at which an injected 
dose of I 131 is organically bound by the gland (85), there is a 
considerable amount of evidence otherwise (86, 87). 
Franklin et al. (88) showed that the capacity of slices of 
sheep thyroid to form diiodotyrosine and thyroxin was inhibited in the 
, 	. presence of thiourea and thiouracil (10 -11), but these drugs did not 
prevent the collection of inorganic iodide in the tissue. This has 
been confirmed by many other workers (83, 84, 89, 90, 91). 
The antithyroid drugs of the thiourea group have provided a 
means of "dissecting" for study the systems of the thyroid involved in 
iodide trapping on the one hand, and hormone synthesis and release on 
the other (91). It is mainly this iodide trapping mechanism which has 
been the subject of many studies, namely the interference of other ions 
in this system. It has been reported that trapping rather than binding 
is the rate limiting step of thyroidal iodine accumulation (92). 
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Bromine has often been thought to play an important part in the 
physiology of the thyroid gland. Bernhardt and Ucko in 1926 (10 
reported that the thyroid contains more bromine than any other tissue. 
This has subsequently been supported by other workers (93, 90. 
Perlman et al. in 1941 (54) using radio-active bromine (Br 82 ) 
found the highest uptake by the thyroid glands in rats and guinea-pigs. 
Hypertrophied glands produced by treatment with thyrotropic hormone 
showed about 30$ increase in the Br82 uptake. Similar results were 
obtained by Baumann et al. in 1956 (55) who showed that from 10 - Elq% 
more Br82 was present per gram of thyroid than per gram of blood. 
Baumann et al. (95), working with rabbits, produced experi-
mental evidence that hyperplastic thyroid tissue of low iodine and 
colloid content has more bromine than the circulating blood, while in 
fully iodized thyroids rich in colloid no more bromine is found than is 
present in the blood. They suggested that the bromine content of the 
thyroid may be explained on the assumption that thyroid tissue can 
distinguish only imperfectly between iodine and bromine. Glands which 
are hyperplastio due to a deficiency of iodine will, in the absence of 
iodine, seize bromine instead. (There is 10 - 100 times as much 
bromine as iodine in food and water.) When iodine is supplied to 
animals with hyperplastic thyroids they quickly lose the accumulated 
bromine. 
This assumption that bromine can be selectively absorbed by 
the thyroid, but cannot substitute iodine in the hormone synthesis, is 
supported by work of Peterson and Yomamoto (96) who reported that a 
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hyperthyroid patient's thyroid concentrated 17 - 2q% of the Br82 
tracer dose, and 55 - wy. of 1131 tracer dose. At 24. hours they found 
57% of the serum 1 131 was organically bound, while less than 0.4% of 
the serum Br82 was organically bound. These data strongly suggest 
that the thyroid significantly concentrates but does not organically 
bind the bromine. 
It seems that bromine will concentrate in an iodine deficient 
thyroid, also that if bromine is administered continuously in large 
doses, it will decrease thyroidal iodine. It has been found (97, 98) 
that continual feeding of sodium bromide to young rats will decrease 
thyroidal iodine with resultant goitre. There is evidence, however, 
indicating that this action is common to all halogens. 
It has been shown (99) that sodium fluoride administered to 
rats for several months caused the development of hyperplastic thyroids 
as much as eight times the normal size. Fluoride has also been 
reported to cause goitre in pigs (100). Thyroid hyperplasia has been 
caused in rats on a diet containing 1 - 4 sodium chloride (101). The 
thyroid iodine was reduced to one third of the amount in the control 
animals. 
Moreover, Williams et al. (102) found that sodium chloride, 
sodium bromide and sodium fluoride caused an augmentation of the goitro-
genesis of thiouracil and. propylthiouracil in rats. Goitres were also 
produced in animals receiving one of the halides and one of the thio-
uracils, when the concentration of the latter alone was too small to 
produce goitres. Fluoride was found to be several times more active 
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than either of the other compounds, while bromide was more effective 
than chloride. They suggested that these variations in results may 
be attributed to differences in permeability of cell membranes to these 
ions. 
On the other hand, the administration of large quantities of 
potassium iodide to rats given thiourea has not produced a significant 
effect on goitrogenesis (103), but when the intake of iodine has been 
low, the amount of thiouracil necessary to produce a goitre has been 
shown to be decreased. Further, it has been demonstrated in rats that 
goitrogenesis was greater with sodium bromide given with propylthio-
uracil than with either one alone or both combined with potassium 
iodide. 
It appears, therefore, that the thyroid gland selectively 
filters all halogens, especially if iodine deficiency is present; 
however, iodide is the only halide that is used in thyroid hormone 
synthesis. Non-iodirle halides administered in large doses have a 
mass-action-like effect, both decreasing trapping and increasing 
discharge of the iodine normally ingested and this eventually leads to 
Ilyperplasia and goitre. In addition, the action of these non-iodide 
halides may also lead to competition of these ions for reabsorption by 
the renal tubules thereby producing an increased rate of excretion of 
iodide (102). 
Fluoride probably produces its effect by mechanisms additional 
to the foregoing one*, since it inhibits many enzymatic reactions 
throughout the body. 
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This competitive action of non-iodide halides is supported 
by reports that these ions may interfere with radio-active iodine 
uptake by the thyroid. Thus, it was shown by Petersen and Yamamoto 
(96) on 28 euthyroid patients that bromide depressed thyroidal 1 131 
uptake. This was supported by Glode et al. (100 who showed on rats 
which were injected with 15 mg of bromide peritoneally daily for 3 - 270 
days, that the longer, bromide was administered, the lower was the I 131 
uptake. In contrast, the I 131 uptake measured on rats which had been 
on water containing bromide (0.15 mg/cc) was higher than in the control 
animals used; however, this was found to be due to increased thyroidal 
mass, not due to the increase of any specific activity (100. The 
glands showed goitrous conditions, which is another indication that 
bromide or any other non-iodide halide will interfere with iodine 
metabolism if administered over a long period and in relatively large 
doses. 
Although there is sufficient evidence indicating that non-
iodide halides interfere with iodine metabolism, there have also been 
a few reports which denied this. It has been shown (84) that bromide 
doses over 500 times that of injected iodide will not cause significant 
iodide displacement. This has been supported by another experimental 
study. Wyngaarden et al. (105) failed to show that the administration 
of fluoride, chloride or bromide in doses of 0.1 M had any effect upon 
1131 accumulated within propylthiouracil treated thyroids. In all 
these cases, however, only a single dose of these ions was used, and 
therefore such results could be expected. 
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Several workers (27, 28) failed to demonstrate preferential 
uptake of Br82 by the thyroid of rabbits and rats. It has been 
suggested by Mack and Shipley (27) that the lack of such selective 
concentration of Br82 in their experimental animals might depend on 
either an accidentally low level of thyroid activity in the animals, or 
the existence of a state of relative iodine saturation. The latter 
suggestion seems the more likely, as the evidence of Baumann et al. (95) 
shows that a significant substitution of bromine for iodine requires the 
presence of a pre-existing iodine depletion. 
Thus it could be stated that in considering the effect of 
non-iodide halides on iodine metabolism the duration of administration 
of these ions is most important. 
Finally it should be mentioned that there is evidence strongly 
suggesting that not only all halogens, but all elements of the 7th 
periodic group are selectively filtered by the thyroid. 
It has been demonstrated (106) that the thyroid glands of 
guinea pigs and dogs which have been injected with manganese chloride 
will store 50 and 49 times respectively as much manganese as the control 
animals. It was found that the thyroidal concentration of radioactive 
manganese (Mn54) was about 10 times that of serum two hours after 
injection (55). 
Rhenium has been shown to be concentrated by the thyroid of 
rats from 25 - 100 times more than by any other tissue (107) after 
injection of radioactive rhenium (Re 186). Also astatine (108) and 
technetium (109) have been found to be preferentially concentrated by 
the thyroid. 
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The experimental evidence indicates that the ability of the 
thyroid to filter and concentrate elements of the 7th periodic group is 
greater for those of high atomic weight than for those of low atomic 
weight (55). 
The questions now arise, how does the thyroid differentiate 
between the above elements and all others, and what is the mechanism of 
action of these interfering elements? 
It must be stated from the outset that little is known which 
can answer these questions, though there is some suggestive evidence 
which may eventually lead to the understanding of these problems. 
Baumann and Metzger (110) suggested that the behaviour of 
these elements is due to the similarity in the arrangement of their 
electrons. Astatine, bromine, chlorine, fluorine and iodine have 7 
electrons in the outer shells, consisting of 2 in the s and 5 in the p 
orbitals. On the other hand, manganese, technetium and rhenium also 
have 7 electrons in their outer shells, but Mn and Re have 5 electrons 
in the d and 2 in the s orbitals, and To has 6 electrons in the d and 1 
in the s orbitals. Wyngaarden et al. (105) failed to flush out accumu-
lated 1 131 in "blocked!' thyroid by doses (0.1M) of fluoride, chloride 
and bromide, but he showed that halogen oxides at the same concentration 
are more effective: perchlorate, periodate, iodate and chlorate caused 
a quantitativeAdscharge of 1 131 in the initial 15 minute period. Bi-
iodate and hypochlorite caused an incomplete discharge, and bromate was 
negative. 
Perchlorate was shown to be most potent in preventing the 
collection of iodide by the thyroid and thus causing goitre (91, 105, 111). 
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Perchlorate reduces simultaneously the concentration gradient and 
inhibits iodide uptake (88, 106). Although the mechanism of its 
action has not been established, there is some evidence suggesting that 
a competition for certain sites in the thyroid cell is involved (105). 
This assumption is supported by the fact that perchlorate concentrates 
in the gland (112) and by the fact that the interference with iodide 
collection caused by perchlorate can be overcome by the administration 
of excess iodide (105). 
The competition between perchlorate and iodide may be due to 
their similar monovalency and size. This is supported by the findings 
that monofluorosulphate and fluoroborate ions which are very similar in 
size and are iso-electronic with perchloratedecrease the iodide 
accumulation in the thyroid to the same extent (112). 
It has been suggested by Anbar and Guttmann (112) that the 
trapping mechanism in the thyroid involves a factor which scarcely 
distinguishes between different anions having the same charge, and 
comparable volume. Such a factor is probably a protein with a special 
arrangement which traps only those ions which fulfil these requirements. 
The mode of action of these ions upon the mechanism of iodide collection 
by the thyroid must await the full understanding of the mechanism by 
which the thyroid is able to accumulate inorganic iodide, and maintain 
g concentration gradient over the serum (105). It must, no doubt, 
involve an active transport of iodide across the cell membrane (113) and 
once in the cell is probably temporarily bound to some organic molecules, 
most likely to a protein. There is evidence which indicates that the 
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presence of intact cells is necessary for iodide concentration, as it 
has been shown that homogenization destroys this activity, most likely 
due to the destruction of cell membranes (114, 115, 116). An 
interesting exception to the requirements for cellular integrity has 
been found in certain fish (salmon, rainbow trout, etc.) with a serum 
protein which binds iodine relatively strongly (117). 
In conclusion it could be stated that the obvious problem is to 
explain the different actions of the elements of the 7th periodic group 
and the halogen oxides. In the absence of any definite experimental 
evidence one can only speculate as to the answer. It is possible that 
there are two different levels or sites where the above ions could inter-
fere by competing with iodide. Very recent work (118) suggests that 
there are two pools of iodide in the thyroid; the first consists of 
"trapped"iodide, and this is used very quickly for thyroid hormone syn-
thesis, while the second iodide pool may be derived from deiodination of 
some of the monoiodotyrosine (M.I.T.) and deiodotyrosine (D.I.T.) which 
are thought to be the first products of thyroid hormone synthesis (119). 
It has been shown (119) that some of the iodide in the thyroid 
cannot be discharged with perchlorate and it seems highly likely from 
experimental evidence that this iodide is from the "second pool". 
It is possible to speculate from this that the relatively fast-
acting halogen oxides interfere by competing for some sites during the 
"trapping" of iodide, i.e. in the first iodide pool (although the nega-
tive bromate remains unexplained) and the somewhat slow-acting ions such 
as bromide interfere with the iodide of the second pool, possibly by a 
simple mass action. 
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PRESENT INVESTIGATION  
AIM. 
Evidence has been presented that if bromide or any other 
halide is administered continuously over a relatively long period, it 
will interfere with iodine metabolism. The clinical importance of 
this interference is its possible adverse effect on thyroid function 
tests. 
An experiment was set up to determine whether bromide or 
fluoride administered over a relatively short period (approximately five 
weeks) would have any effect on thyroid function; if so, it would be an 
adverse factor in the estimation of protein bound iodine in patients who 
had been on some bromide medication, including "Relaxa-Tabs", or who had 
consumed relatively small amounts of fluoride. 
METHODS AND RESULTS. 
The guinea-pigs were divided into three groups of 3 to 4. 
animals: 
Group A - Control - Normal food + distilled water. 
Group B - Bromide - Normal food + 400 p.p.m. of bromide 
(NaBr) in drinking water. 
Group C - Fluoride - Normal food + 2 p.p.m. of fluoride 
(NaF) in drinking water. 
(A low concentration of fluoride was used because of its 
possible effect on the enzyme system in the body.) 
64.. 
Any effect of bromide or fluoride on thyroid function may 
manifest itself by interference with (a) the iodide concentrating 
mechanism, (b) thyroid hormone synthesis and (c) the binding capacity 
of the serum proteins. Therefore after five weeks three standard tests 
were performed: 	(i) 1131 uptake, (ii) protein bound iodine (P.B.I. 131 ) 
and (iii) T3 resin uptake. 
1. Radio-active iodine uptake. 
The animals of all three groups were treated in the same way. 
An activity of 5 juCi of 1131 was injected into the peritoneal 
cavity of each guinea-pig. At three hour and 24 hour intervals follow-
ing injection the radioactive measurements were made in vivo by placing 
3 of the animals from each group in a specially designed plaster-cast 
restrainer with a lead shield leaving only the thyroid zone exposed. 
A scintillation detector with a sodium iodide crystal was used. This 
was placed at a distance of 30 am from the thyroidal area in each case. 
A standard of 5 pCi of I131 in a bottle was used as the log% reference. 
The fourth guinea-pig was measured for radioactivity in the same way, 
except that the timing was in half-hourly intervals up to three hours. 
Blood was then taken from all animals by heart puncture for 
further examination, mainly P.B.I. 131 and T 3 uptake tests. The radio-
activity due to protein bound radioiodine is insufficient to affect the 
result of the T 3-resin uptake. The guinea-pigs were killed under 
anaesthesia and the thyroids then dissected and fixed in formalin for 
histological examination. 
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2. Radio-active protein-bound iodine. 
For this experiment the method of Silver (120) was used. 
In principle it involved the following: blood was collected 72 hours 
after the intraperitoneal administration of 5 pei of radio-iodine. The 
serum proteins were precipitated with l0 trichloracetic acid, washed 
with distilled water and then dissolved in 2.5 N NaOH. The radio-
activity was expressed as a percentage of the administered dose per 
litre of serum and indicates the amount of I 131 labelled thyroxin, i.e. 
the rate of production of hormone by the thyroid gland. 
3. Resin uptake of I 131-Tri-iodothyronine (T 3 uptake). 
The method of Nava and De Groot (121) was used, the principle 
of which is: I131 labelled tri-iodothyronine is added to serum and 
resin and these compete for the tracer. The amount taken up by the 
resin is inversely proportional to the binding capacity of the serum 
proteins for the thyroid hormones. 
The results of the above experiments are shown in Table 15, 
Figure 4. 
DISCUSSION.  
It is difficult to assess Whether there was any significant 
decrease in the three hour 1 131 uptake in the bromide group considering 
that only three animals were measured, but it appears that there may 
have been some lowering effect. As shown in Figure h. there was no 
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significant difference during the first three hours in the 1 131 uptake 
rate between the control and the bromide treated guinea-pig. 
The F.B.I. 131 results show, on the average, an increase in 
the bromide group as compared with the control. Since there was no 
difference between these two groups in 131 uptake, the possible 
increase of F.B.I. 131 in the bromide group might suggest the stimulating 
effect of bromide on the enzyme systems of the thyroid gland. In the 
fluoride group, however, the result was suggestive of the lowering 
effect of fluoride on the production of thyroid hormone, and because 
the I131 uptake was normal in this group it is likely that any fluoride 
effect on thyroid. function is exerted on the synthesis of the hormone 
itself in the gland. 
Considering that only a relatively low concentration of 
fluoride was used, compared with bromide, the above results would support 
the previously mentioned suggestion that fluoride, in addition to its 
competitive action with iodide, will also affect enzyme systems in the 
thyroid gland. 
The fact that only 3 to If animals were used in each group 
must be taken into consideration before any definite conclusions are 
drawn concerning the effect of bromide or fluoride on thyroid function. 
That the serum binding capacity was not affected by the above 
ions was indicated by the T 3-resin uptake test, which showed no 
significant difference between the three groups of guinea pigs. 
The histological examination of the thyroid glands of the 
animals showed no evidence of goitre. 
TABLE  
THE EFFECT OF BROMIDE AND FLUORIDE INTAKE 
ON THYROID FUNCTION IN GUINEA-PIGS  
No. 
animal Control Average Bromide Average Fluoride Average 
3 hour thyroidal f-I  C
V
 	
1'41
 	
. 
25.4. 23,5 20,6 
uptake of 1131 27.5 29.7 26.4 25.5 24.3 27.0 
% of A.D. bf 
1131 36.3 26.7 36.1 
24 hour thyroidal 
uptake of 1131 
1 
2 
25.3 
28.7 22.6 
28.7 
24..6 27.1 
20,4. 
26.0 22.0 % of A.D. of 
1131 3 14..1 28.1 19.8 
PBI131% of 2.3 3.0 1.8 
A.D./litre 
serum 
3 '5 7.0 6.5 8 '0 13.2 10.0 35 6.0 3.8 
13,2 15,7 
I 
T3-resin uptake % 67.5 72.5 70.0 70.0 69.6 74.0 74.3 71.0 70.5 
72.0 75.0 
76.0 
. • I . . . • 
THYROIDAL _UP_TAKE.OF_ 1 131 
I N GUINEA . PIG LOADED_ WITH _ BROMIDE 
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CHAPTER IV  
THE EXCRETION CF BROMIDE 
The rate of bromide elimination from the body is very slow. 
Ucko in 1936 (16) reported that an increased amount of bromide in the 
blood and tissues can be found many months after the intake of bromide 
has ceased. Andrews (122) has shown that in humans it takes on an 
average between five and eight weeks to drop from a flame between 150 
and 200 mg of bromide per 100 ml of serum back to normal (0.21 to 0.29 
mg Na Br/100 m1). 
Bromide, as chloride, is excreted mainly by the kidneys. 
Damiens in 1920 (52) reported the presence of bromide in human urine 
and claimed that normally from 0.3 - 0.75 mg of bromide/100 ml is 
excreted therein. Higher figures were obtained by Ucko in 1936 (16) 
who claimed that the bromide level in 24. hour urine specimens varied 
from 1.0 - 2.5 mg/100 ml. SOremark (123) found that nearly all radio-
bromide administered was excreted by the urine while the excretion of 
bromide by the faeces was extremely low. The loss of bromide in the 
urine is found to be variable and not to correspond always with the 
serum bromide level so that while in general a high bromide level in 
urine is found when the level in serum is high, this is not invariably 
so (122). 
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It has been demonstrated (17) that, although bromide replaces 
chloride in the body, the total content of halides in the body remains 
relatively constant. If bromide is administered, a corresponding 
quantity of halide is excreted with the result that the total halide 
content is undisturbed. There have been, however, conflicting reports 
as to whether the kidneys distinguish between these two ions. The 
early workers, Frey (1932) (124) and Moller (1932) (125) believed that 
the kidneys do not distinguish between chloride and bromide. This has 
also been claimed in some textbooks (126), but is disputed by other 
workers according to whom the kidneys seem to have a greater ability to 
excrete chloride than bromide (22, 23, 127). 
Hastings et al. (22) showed that the excretion of chloride 
following a sodium chloride injection was practically equal to that 
following a similar injection of sodium bromide, and that the excretion 
of chloride and bromide was not proportional to the ratio of these ions 
in the serum. 
Palmer and Clarke (23) presented data showing that the 
percentage of bromide in the urinary halides is lower than that in the 
blood halides. Further, that not only does the kidney excrete a 
smaller proportion of the bromide than of chloride, but the magnitude 
of this proportion appears to depend on the level of chloride intake. 
The ratio of the fraction of bromide to total halide in the urine to 
that in the blood is constant during a constant chloride intake. When 
the chloride intake is raised this ratio also rises, thus on a salt-poor 
diet it was 0.40 and on a high salt diet it was 0.70. They concluded 
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that this ratio depends upon the amount of halide being excreted and is 
independent of the blood bromide level, moreover, no relationship 
exists between urinary volume and bromide excretion. Following the 
chloride injection, the excretion of bromide and total halide, the 
urinary volume and the ratio of bromide to the total halide in the urine 
to that in the blood all rose; after an injection of urea, however, 
there was an increase in urinary volume comparable to that caused by the 
chloride injection, but the other figures showed no corresponding rise. 
Following the administration of chloride, the changes observed in the 
bromide excretion are therefore the result of a rise in halide excretion 
and not of changes in urinary volume (23). These results serve to 
explain the clinical observations that bromide intoxication responds to 
the administration of chlorides but not of other diuretics. 
Mason (24) supported these findings when he reported his 
observation on dogs which had been given caffeine followed by 250 cc of 
5g glucose intravenously, indicating that the resultant diuresis did 
not significantly alter the ratio of "replacement". He used the term 
"percentage replacement" (replacement of chloride by bromide) for halide 
distribution between serum and urine. 	If the kidney did not differen- 
tiate between bromide and chloride, as has been claimed by some, the 
replacements in the urine and serum would be equal in simultaneously 
collected samples, i.e. R urine/R serum would equal unity, where R is the 
ratio (expressed as a percentage)of bromide to bromide plus chloride, i.e. 
Br x 100  . However he found that in dogs the ratio in replacement was (Br + C1) 
0.7. In the cases of patients, the ratios were more variable, and 
higher. The data indicated that for humans the value of the ratio of 
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replacement varies with the individual, but is nearly constant for a 
given individual. This individual variation might well have some 
bearing on the clinical observation that the amount of bromide used for 
producing bromism differs with the individual, as it is well known that 
the level of serum bromide at which symptoms of intoxication are 
manifested is variable. 
Baumann et al. (95) subsequently showed that rabbits fed on 
a relatively low chloride diet had a high serum bromide level (2 -3 mg/ 
100 ml)and on 51, dietary chloride increase o the blood bromide level 
dropped to about half of the original level. The variations of blood 
bromide on a constant diet are not more than 0.3 mg/100 ml. 
The direct influence of chloride on the blood bromide level 
and its excretion was also reported by Evans (17) who suggested that, 
although after a single injection of bromide the kidneys will excrete 
a corresponding quantity of halide, the proportion of bromide in the 
excreted halide will be somewhat smaller than found in the serum; 
therefore it will take a relatively long time for all bromide to be 
excreted. However, if large doses of chloride are administered after 
the injection of bromide, the total output of halide will be increased 
considerably. Bromide will still be only a small proportion of the 
total halide excreted, but, as a result of the increased total output, 
the absolute quantities of bromide excreted will be increased, and 
bromide will be completely eliminated from the body more quickly. 
Bodansky and Modell (128) have also demonstrated that there is 
a preferential excretion of chloride by the kidney at the expense of 
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bromide, and claimed that this is an important factor in the accumulation 
of bromide in the body. They suggested that the preferential excretion 
of chloride appears to depend upon the extent of reabsorption in the 
tubules. According to them, chloride and bromide are passed into the 
glamerular filtrate in an unselective manner, but bromide is reabsorbed 
much more quickly than chloride by the renal tubules. The result is 
that the proportion of bromide to total halides is less in the urine than 
in the blood. These workers supported their suggestion by the findings 
that the injection of mercurial diuretics caused a very large increase 
in the total halide excretion by the kidney, and also that the proportion 
of bromide to total halide in the urine so formed was increased and 
approached the proportion found in the blood. The current theory of the 
mode of action of mercurial diuretics is that they produce a diuresis by 
reducing the rate of tubular reabsorption of sodium with accompanying 
anions and water, without affecting the rate of glomerular filtration 
(129, 130). 
The preferential excretion of chloride thus appears to depend 
upon the extent of reabsorption in the tubules. Theoretically, by 
producing a sufficiently high halide excretion a point could be reached 
where the ratio of bromide to total halide would be nearly the same in 
the urine as in the blood. Frey (131) has recorded values which indicate 
such a condition in the rabbit, but this point was not reached by Palmer 
and Clarke (23) who found that after the injection of sodium chloride into 
dogs the above ratio was about 0.70. 
Excretion of Organic Bromine. 
As discussed in Chapter V, most of the bromine ingested by 
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humans is in organic form, mainly as carbromal and branvaletone. It 
is important therefore to have some knowledge of the way in which this 
organic bromine is excreted. 
It is known that the hydrolysis of carbromal (bromo-diethyl-
acetylurea) and bromvaletone (bromo-dimethylpropylurea) gives urea and 
a corresponding brominated fatty acid, i.e. bromo-diethylacetic acid or 
bromo-dimethylpropionic acid. The manner of degradation of the bromo- 
fatty acids with the release of inorganic bromide has not been established 
as yet (132). According to Stohr (133) most of the carbromal ingested 
by animals is excreted in three forms, viz. inorganic bromide, bromo-
fatty acid and an ether soluble substance containing bromine, and very 
little is excreted unchanged via the kidneys. 
Wollheim (134) compared the excretion of bromine in organic 
and inorganic combination after bromo-ureide intake. He found that 
only from 1.6 to 64% of the bromo-ureide bromine was excreted in 
organic combination (the figure depended upon which bromo-ureide was 
used). This was eliminated promptly within three days of ceasing 
bromo-ureide intake, whereas the rest of the bromide was excreted in the 
inorganic form with the usual slow elimination characteristic of this 
form of bromide. 
Diurnal Rhythm. 
It is known that varying quantities of urine and electrolytes 
are excreted by humans in a diurnal pattern (variation rhythm) (135, 136). 
In temperate climates about two-thirds of the excretion of water and 
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sodium occurs by day and there is a relative antidiuresis at night. 
This normal rhythm is well maintained even though the length of day 
is changed drastically or sleep is reversed (136). 
According to MacFarlane (137) the diurnal rhythm is reversed 
in the dry tropics l and considerably less water and sodium are excreted 
by day than at night, especially during acclimatisation. The main 
excretion of sodium is nocturnal, providing that the night is cooler than 
the day. 
There is some evidence showing that bromide is also excreted 
in a diurnal pattern. Ucko (16) reported that the bromide content in 
urine varied considerably in samples passed at different periods of the 
day. SOremark (123) using radioactive bromide in humans showed that 
bromide is excreted in a diurnal rhythm. He claimed that during sleep 
there was hardly any bromide excreted. 
The Effect of Thyroid Hormone on Bromide Excretion. 
There is mounting evidence that the thyroid hormone affects 
the renal function, i.e. the secretory function of the renal tubules is 
Increased in hyperthyroidism and decreased in hypothyroidism (138, 139, 
140). This has also been .demonstrated in relationship to bromide 
excretion. Although some early workers (141, 142) claimed that when 
animals are fed on desiccated thyroid the blood bromide level rises, this 
has been disputed by Baumann et al. (95) who showed on the contrary that 
after feeding desiccated thyroid to animals the bromide level in blood 
decreased, but the fall did not occur until from two to three weeks after 
medication and then the blood bromide slowly rose to normal. Also, 
when rabbits with hypertrophied thyroids were given iodide, excessive 
thyroid secretion occurred with a resultant gradual fall in the blood 
bromide level (from 35 - 50) and again the decrease was not evident 
until about two weeks after the iodide was given. 
The lowering of blood bromide either by feeding thyroid or by 
the excessive thyroid secretion of goitrous rabbits given iodide can be 
ascribed to the fact that the thyroid hormone acts on the kidney to 
increase renal function (143, 144), thus greater amounts of bromide as 
well as other salts are excreted. 
Bromide Excretion Other Than Through the Kidney. 
Although most of the excreted bromide is found in the urine, 
small quantities are excreted in the sweat, tears, saliva and gastric 
juice (17). Mason (24) found that human mixed saliva had a much 
greater replacement of chloride by bromide than the serum. He 
concluded therefore that one or more of the human salivary glands must 
preferentially secrete bromide to a marked degree. SOremark (123) 
claimed that the mean concentration of Br 82 in human urine and saliva 
was about equal, and 	times that of the blood level. 
Nencki and Schoumow-Simanowdki in 1894 (61) observed the 
presence of bromide in the gastric juice of dogs given bromide. 
Davenport and Fisher (1940) (58) have clearly shown that in the Pavlov 
pouches in dogs the rate of secretion of bromide is of the same order as 
the rate of secretion of chloride and the concentration of bromide in 
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the gastric juice is about 50/4 higher than in plasma. However, the 
volume of gastric juice in any short period could not be more than from 
3 - 410 of the volume of the extracellular fluid. Hunter et al. (29) 
therefore suggested that, with only a 5Cro excess of bromide in gastric 
juice over the plasma level, this could not be regarded as likely to 
change the plasma level. Thus a fall in plasma bromide level of more 
than 1 - 470 following a very active period of gastric secretion would 
not be expected, and such all alteration is within the usual analytical 
variations. Therefore it could be stated that the gastric secretion 
is not a very significant factor in lowering serum bromide. 
Bromide is also secreted in the milk and it easily crosses the 
placental barrier (17). Lynn et al. (145) reported that bromide is 
secreted in the milk of lactating dairy cows when the element is present 
in their diet ) as a result of naturally occurring bromide in forage or 
grain, added sodium bromide,or inorganic bromides arising from methyl 
bromide fumigations. The amount of bromide in the milk is proportional 
to that in the diet and. appears to be correlated to levels of bromide in 
the blood. A total diet containing 4-3 p.p.m. bromide resulted in 10 to 
20 p.p.m. bromide in milk with no effect on production. 
In conclusion, it could be stated that there are many ways by 
which bromide can be excreted from the bodies of humans and animals. 
However, the kidneys are by far the most important excretory organ, 
although the amounts of bromide eliminated from the body of lactating 
animals and humans is certainly significant. 
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PRESENT INVESTIGATION 
AIMS. 
(a) To investigate the bromide excretion rate of the "normal" 
human body. In this experiment, human subjects were chosen because 
of the clinical importance of this aspect and for the easier control 
of the collection of urine, etc. 
(b) To study the effect of a dose of bromide on other serum and 
urinary electrolytes, mainly that of chloride, in view of the claim by 
Palmer and Clarke and others that chloride is preferentially excreted 
by the kidney. 
(c) To determine whether bromide is excreted in the same diurnal 
pattern as chloride. It is known that chloride is excreted in a 
diurnal variation, and that bromide can replace chloride in the body, 
therefore the excretion pattern relationship between the two ions was 
considered to be of some interest. 
METHODS AND RESULTS. 
(a) Excretion Rate. 
In these experiments, both radioisotopic and chemical 
techniques were used. 
(1) Retention Test - using a whole body monitor: 
The retention time of bromide in man was measured. For this 
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purpose 4 human subjects (3 males and 1 female) took an oral dose of 
. radioactive bromine (KBr 82  ) of 1pCi of activity, and the overall 
activity was measured at several intervals in the whole body monitor. 
The results of this experiment can be seen in Table 16 and Figure 5. 
The following comments should be made with regard to these 
results: 
(i) The reading immediately after the oral dose is on an 
average 8% lower than the values obtained between 1 and 3 hours 
after zero time. The measurement at one hour was therefore taken 
to represent the 100% retention value. The reason for the above 
is that there is greater accuracy in counting a dispersed source 
than a point source, and immediately after the oral intake of 
K Br82 this is mainly confined to the stomach. 
(ii)In the case of subject B, a one-hour measurement was not 
made, therefore the three-hour value was taken as 100%; this 
however did not give rise to any significant error, as the average 
retention at 24. hours of the four subjects was Aro. 
(2) The Bromide Excretion Rate of One Human Subject: 
The bromide level in the serum and urine of one human subject 
was estimated for several days before a single dose of potassium bromide 
0.5 g was taken orally. Blood samples were then taken at two or more 
day intervals; pooled A.-hour urine specimens were collected daily for 
approximately five weeks, and the bromide level estimated in each. 
The results, as indicated in Table 17 and Figure 6, showed the 
relatively slow excretion of bromide. 
TABLE 16  
RADIOACTIVE BROMINE RETENTION TEST IN THE HUMAN  
(using a whole body monitor following oral administration of -- 
1 pCi of Bro2 
Subject Sex Age Weight in kg 
Time after 
dose % retention 
Biological 
half-life 
A F 19 yrs. 60.4 0 hrs. 93.2 140 hrs. 1 hr. 100 3 hrs. 101.3 24. 	" 97.2 120 	" 59.4 169" 40.0 
B M 38 yrs. 76.7 •
 • 
.h
  
r-I 
88.8 160 hrs. 
100 
58.0 
• 38.0 
C M 25 yrs. 68.0 0 hrs. -- 124. hrs. 1 hr. 100 
24. hrs. 100 96 	II 63.0 
• 150 	" 40.0 
D IL 23 yrs. 79.0 0 hrs. 94.3 134. hrs. 1.3 	" 100 3.5 	" 97.0 23.5 	" 99.0 124 	" 54.0 
_ 197 	" 34.0 
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TABLE 17 
Date 
Urine Serum 
pg Br/aa. Volume hrs. pg Br/ml mg Br/24 hrs. 
11.5.65 950 3.8 3.6 
12.5.65 990 5.7 5.6 4.3 
13.5.65 1,330 3.5 4.7 4.0 
*17.5.65 2,230 6.0 13.4. 6.7 
18.5.65 1,400 9.6 13.4. 8.9 
19.5.65 1,180 9.0 10.6 8.8 
20.5.65 1,300 8.8 11.4 8.2 
21.5.65 1,220 10.2 12.4. 8.1 
22.5.65 1,420 7.8 11.1 
23.5.65 1,570 10.0 15.0 
25.5.65 1,650 6.4 10.6 6.5 
26.5.65 1,000 9.1 9.1 
27.5.65 1,250 7.8 9.8 
28.5.65 1,250 9.4- 11.8 6.6 
29.5.65 1,350 8.1 10.9 
30.5.65 1,4.00 6.3 8.8 
31.5.65 1,250 8.8 11.0 
2.6.65 1,000 9.7 9.7 
3.6.65 1,550 7.0 10.9 6.8 
5.6.65 1,000 6.9 6.9 
6.6.65 900 7.3 6.6 
7.6.65 850 7.2 6.1 
11.6.65 1,500 6.4 9.6 5.9 
13.6.65 800 6.0 4.8 
14..6.65 1,000 5.3 5.3 
15.6.65 1,350 5.6 7.6 
19.6.65 1,450 3.7 5.4- 
20.6.65 	.. 1,600 3.7 .. 5.9 A 
* Dose of 0.5 g K Br taken orally. 
I 
5?6 
_SERUM_ AND URINARY BROMIDE LEVELS 
FOLLOWING INGESTION OF KBi. 
It 
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(b) The Effect of Bromide on Other Electrolytes,. 
Simultaneous investigations on the serum and urinary electro-
lytes following a dose of potassium bromide were carried out. The 
sodium and potassium content was measured on an Eel flame photometer and 
the chloride was measured by a mercuric nitrate titration method (146). 
The results are shown in Table 18 and Figure 7. 
(0) Diurnal Rhythm. 
(1) In this experiment urine specimens were collected a . 	and 
eight hourly intervals for eight days from one human subject, and for 
three days from another. The volume of each individual specimen was 
measured and the urinary sodium, potassium, chloride and bromide contents 
were estimated. The results of these studies show the relative 
similarity of the diurnal excretory patterns of these ions, as seen in 
Tables 19a - d, and Figure 8. As both sets of results follow the same 
pattern, only one set is shown. 
(2) The osmolality of each urine specimen was determined by a 
measurement of the freezing point depression. The depression of 
freezing point is determined by the number of osmotically active 
particles present per kg of solvent, and is linear within the range. 
The urine osmolality is highest in the early morning specimen 
and lowest in the afternoon specimen. This is a reflection of the 
diurnal rhythm in the release of the anti-diuretic hormone from the 
posterior pituitary (147, 148). This hormone acts directly on the 
distal renal tubules to promote the reabsorption of water and consequently 
TABLE 18 
Urinary Electrolytes Serum Electrolytes 
Date 
Urinary 
volume 
m1/24 hrs. 
Na 
meq/ 
24. hrs. 
K 
meg/ 
24. hrs. 
Cl 
meal 
24. hrs, 
Na 
me q/1 
K 
me q/1 
Cl 
meg/l 
Total 
protein 
is/100 ml 
11.5.65 950 161.5 60.8 171 14.1 3.9 102 6.7 
12.5.65 990 227.7 63.3 24.3.5 137 4.2 107 6.7 
13.5.65 1330 199.5 85.1 215.4. 
17.5.65 2230 205.1 624 200 137 3.8 102 6.6 
18.5.65 1400 203 56 186.2 126 5.0 97 6.1 
19.5.65 1180 165.2 61.3 174.6 137 4.0 104. 7.1 
20.5.65 1300 182 65 195 135 4.3 102 
21.5.65 1220 225.7 82.9 256.2 137 4.0 104. 7.0 
22.5.65 1420 241.4. 71 249.9 
23.5.65 1570 251.2 72.2 259 
25.5.65 1650 184.8 66 199.6 
4 4 0 3 
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TABLE 19a, 
DIURNAL RHYTHM 
Day 1 2 
Period of day 
12 MN 
J. 
6 AM 
6 AM 
4, 12 MD 
12 MD 
4, 6 PM 
6 PM 
12 MN 
Total 
/ 24 hr. 
12 MN 
,J, 
8 AM 
8 AM 
4, 
4 PM 
4 PM 
4, 
12 MN 
Total 
/ 
24. hr. 
Urinary volume 
/m1 160 260 290 400 1,110 600 420 880 1,900 
mg Br/ 
specimen 0.42 1.30 1.07 1.00 3.79 1.11f. 2.10 1.32 4,56 
m-equiv C11 
specimen ' 16.8 48.8 49.2 41.2 156 54.4 84.0 65.5 203.9 
m-equiv Ned/ 
specimen 17,6 51.9 44.9 41.2 155.6 55.6 94.5 70.1 220.2 
m-equive/ 
specimen 10.2 22.3 19.1 17.6 69.2 34.7 34.4 22.8 91.8 
Osmolality 958 1064 968 583 593 859 355 
Osmolality 
m-equiv le/  
specimen 
m-equiv Na+/  
specimen 
m-equiv C1/ 
specimen 
mg Br/  
specimen 
[ Urinary volume 
/ml  
Period of day 
Day 
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TABLE 190  
DIURNAL RHY THM 
• 	Dag 5 6 
Period of day ,4  
8 AM 
4. 
4. PM 
4. FM 
4, 
12 MN 
Total 
/ 
24. hr. 
12 MN 
4. 
8 AM 
8 AM 
.le 
4. FM 
4
 Total 
/ 
24. hr. 
Urinary volume 
/ ml 180 4.00 4.70 1,050 300 4.50 620 1,370 
mg Br/ 
specimen 0.4.5 1,24. 1.27 2.96 0,75 2.12 1.24. 4..11 
m-equiv C1/ 
specimen 25.2 62,0 64.6 151.8 31.5 91.4 50.3 173,2 
m-equiv Na,' 
specimen 26.1 62.8 74.1 163 30.0 85.6 4.9.7 165.3 
m-equiv Ei./ 
specimen 15.5 26.4 19.8 61.7 15.0 32.4 19.9 67.3 
Osmoladity 9.66 794. 733 700 
' 
859 436 
TABLE 194 
DIURNAL RHYME  
Day 
, 
7 8 
Period of day 
M---)4  
A
 °3  
8 AM 
4/ 
4. PM 
4. FM 
4, 12 MN 
Total 
/ 24 hr. 
M
--g 
A
 '  
6 AM 
4. 12 MD 
Q-.M
 
A
 "   
6 FM 
4, 12 MN 
Total 
/ 24 hr. 
Urinary volume /61 460 400 330 1,210 330 330 630 250 1,560 
mg Br/ specimen. 1,20 2,0 1.38 4.78 0.66 1,23 2.21 1.15 5.24 
m-equiv C1/ 	, specimen 44.2 72.4. 64.7 181.3 24.1 4.8.3 82.3 47.8 202.5 
m-equiv Na+/ specimen 47.0 84.0 76.9 207.9 27.7 48.9 74.7 50.0 201.3 
m-equiv e/ specimen 25.8 36.8 23,1 85.7 13.9 20.3 31.6 13.5 79.3 
Osmolality 387 835 871 548 632 484 748 
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there is a reciprocal relationship between urinary volume and 
concentration. The relationship between urinary volume and osmolality 
is shown in Figure 9. 
DISCUSSION. 
(a) Excretion Rate. 
It can be seen from the results of the retention test that any 
significant excretion of Br82 occurred only after the first 24 hours 
following administration, as during this period only 2 - 1g of Br 82 was 
excreted from the body. The average time of 5% retention, i.e. the 
average biological half-life in 4 human subjects, was 140 hours (6 days) 
which is lower than the figure of 8 days quoted in "The Recommendation 
of the 	- Permissible Dose for Internal Radiation", p. 174 (1959) 
and also that of SOremark (123) who claimed that it was 12 days. 
These results differed from those of Cheek (149) and Forbes 
et al. (150) who reported that after ai hours the distribution of bromide 
reaches a stable level and at the most increases by gg from 3 to 24 hours 
and thereafter may remain constant for several days. 
The 6 day bromide biological half life was also found to be 
the case following the oral intake of 0.5 g potassium bromide, as shown 
in Figure 6. This bromide estimation, which was made by chemical means, 
also indicated that although the serum and urinary bromide levels 
increased after the dose of K Br, the serum bromide level dropped by 5Cro 
in about one week, while the urinary bromide level which was subject to 
80. 
considerable variation by comparison took about 2 weeks to drop to the 
50% level and did not reach normal values until 4 weeks had elapsed. 
These findings support the claim of Palmer and Clarke (23) that bromide 
excretion is not always dependent on the serum bromide level. 
The R urine/R serum bromide ratio was also calculated from 
available data which covered a period of 8 days, where R is the ratio 
of bromide to bromide plus chloride. The results are shown in the 
following table: 
urine/R serum ratio (RuAs 
m-eq Br/i urine  where R urine - (m-eq Br/1 urine + m-eq C1/1 urine) 
and R serum m-eq Br/i serum  - (m-eq Br/1 serum + m-eq C1/1 serum) 
A single dose of K Br 0.5 g was taken orally. 
Date Br Br 	Uri ne Ru/Rs Serum Br +Cl Br +Cl 
4 days before dose: 
12.5.65 0.000504 0.000288 0.57 
Day of dose: 
17.5.65 0.000822 0.000832 1.01 
18.5.65 0.001143 0.000901 0.79 
19.5.65 0.001056 0.000756 0.72 
20.5.65 0.000999 0.000733 0.73 
21.5.65 0.000979 0.000604 0.62 
81. 
In considering the Ru/Rs ratio it is necessary to point out 
that before the intake of 0.5 g K Br this figure was 0.57 (see above 
table). During the first 24 hours following the dose of K Br the 
ratio rose to 1.01, then on the second day it dropped to 0.79, while on 
the fourth day it was 0.62. Therefore, the Ru/Rs ratio reached unity 
only within the first 21 i. hours. At first sight it may appear that 
this sudden increase was due to a greatly increased urinary output of 
2,230 m1/24 hours, as compared with an average of approximately half 
that amount on the preceding 3 days (see Table 17). Closer examination 
reveals that, although the urinary output returned to its previous 
average amount on the subsequent four days, the urinary bromide level 
remained high throughout this period. There must therefore be another 
reason for the Ru/Rs ratio reaching unity during the first 24. hours after 
the dose. If this 1.01 ratio is compared with one of 0.79 obtained the 
following day, some reasons for this difference can be seen. 
Firstly, before the administration of bromide the average 
daily bromide excretion was approximately 4.6 mg. The dose taken was 
0.5 g K Br, which represents 335 mg of bromide, and during the first 
24 hours 13.4 mg of bromide was excreted which was 8.8 mg (13.4 - 4.6 mg) 
above the normal daily excretion. This represents approximately g% of 
the total amount of K Br. In the retention experiment on 4. human 
subjects it was shown that during the first 24. hours only 2 - 3% is 
excreted; therefore the findings of both experiments are in agreement. 
However it is known (see Chapter I) that it takes approximately 
24 hours after the intake of bromide for equilibrium to be established. 
82. 
During the first day after intake the serum bromide level was 6.7jug/ml, 
and on the second and subsequent days 8.9jag/ml. It is this lower 
Br  serum bromide level during the first 24 hours which affects the Br + Cl 
ratio in the serum, as an increased amount of bromide is excreted in the 
urine regardless of the serum level, and thus the Ru/Rs ratio increases 
to unity. On the second day the bromide becomes more evenly distributed 
throughout the body; therefore the serum bromide level increases while 
the urinary bromide is almost unchanged, and thus the R serum increases 
and the Ru/Rs ratio is decreased to 0.79. 
The Ru/Rs ratio was also performed on three human controls 
with normal serum bromide levels with the resultant figures: 0.42, 
0.62, 0.68, all well below unity. These results and also the figures 
seen in the above table support the findings of other workers who 
reported that bromide is not excreted by the kidney at the same rate 
as chloride (23, 24, 71). 
As has been mentioned, the increased urinary volume was not 
alone responsible for the increase in bromide excretion and the Ru/Rs 
ratio of unity. The relationship between the urinary volume and the 
concentration of bromide and of other electrolytes excreted was also 
investigated and is shown in Figures 10 and 11. The correlation co-
efficient (0 for urinary volume (x) and. urinary bromide concentration 
(y) was calculated according to the formula: 
ix -x) (y - Sr- ) - r =  	where x = mean of all x values, y = mean crx cry 
of all y values; Crx = standard deviation of all x values and Cry = 
standard deviation of all y values, and N = number of observations. The 
result of r = 0.60 and this did not indicate a high degree of correlation. 
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(b) An investigation of the serum and urinary electrolytes following 
this single dose of K Br showed. (seeFigure 7) that in the serum there 
was a drop in the levels of sodium and chloride ) and a rise in that of 
potassium during the first 24 hours ) which levelled off to normal in 48 
hours. In the urine there was an increase in the levels of sodium and 
chloride and to a lesser extent of potassium, but this was not observed 
until 3 — 4- days after the dose of K Br. 
(c) The diurnal rhythm of bromide excretion follows very closely 
that of sodium and chloride, as is shown in Figure 8. Table 19a - d 
indicates that the bromide content in the early morning specimens 
(i.e. from 12 m e n. to 6 — 8 a.m.) was lowest on all 8 days when compared 
with specimens collected during the day and in the evening. This was 
true regardless of the urinary volume of the early morning specimens. 
The relationship between the urinary volume and electrolyte 
(including Br) excretion was also studied. The relationship between 
individual volumes and the bromide and chloride excretion in individual 
specimens for each of 8 days is seen in Figure 12, and a similar 
relationship for sodium and potassium in Figure 13. The total urinary 
volume per day was compared with the total excretion of bromide and 
chloride per day also. This is shown in Figure 14, and for sodium and 
potassium in Figure 15. The correlation coefficient (r) for the total 
daily urinary volume and urinary bromide concentration was calculated. 
This parameter was also estimated for sodium, potassium and chloride for 
comparison. 
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- The results of r were: 	Br = 0.73 
Cl- = 0.85 
Na
+ 	0.76 
+ = 0.78 
These results do not indicate a high degree of correlation between the 
urinary volume and the concentration of the above ions excreted in 24- 
hours. 
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CHAPTER V 
PHARMACOLOGY AND TOXICOLOGY OF BROMIDE 
PHARMACOLOGY. 
Inorganic bromide is readily soluble in water and is rapidly 
absorbed into the bloodstream from the intestine (17). After 
absorption it is distributed throughout the body in almost precisely the 
same way as chloride, i.e. mainly in the extracellular fluid. It is 
generally assumed that bromide does not penetrate the cell membrane of 
most tissues except perhaps that of the thyroid and the red blood cells. 
However, Brattgard and Lindgvist (1954) (151) who studied the distribution 
of radioactive bromide in cats reported that bromide does occur in the 
cytoplasm and nucleus of the nerve cell. 
THE MODE OF ACTION OF BROMIDE. 
Bromide produces depressed activity of the central nervous 
system. This specific action is produced solely by the bromide ion 
and not by bromine in other forms such as bromates or organic compounds 
(17). Organically-bound bromine is a constituent of certain sedative 
drugs; however, there is strong evidence indicating that these drugs 
liberate bromide ions during their metabolism. The bromide ions bring 
about the depressing effect on the central nervous system by acting 
directly on the nerve cell. The exact mechanism of this action is 
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unknown. Harris and Derian (1949) (152) have suggested that bromides 
produce their action by interfering with the formation of co-enzymes 
I and II, and that this action can be abolished by the administration 
of massive doses of nicotinic acid (this vitamin is necessary for the 
formation of co-enzymes I and II). This hypothesis is supported by 
their experimental findings of an increase in urinary excretion of 
porphyrins in dogs deficient in nicotinic acid, and also in dogs 
maintained at a blood bromide level of 300 mg/100 ml. There was, 
however, a complete absence of toxic manifestations in a third group of 
dogs with a serum bromide level of 300 mg/100 ml but on a diet 
supplemented with nicotinic acid (152). 
Six patients with high blood bromide levels were also studied, 
and in all cases the excretion of coproporphyrin was found to have 
increased above normal levels. Two of the patients were treated with 
niacinamide in conjunction with sodium chloride therapy and the remaining 
four patients were given niacinamide only, while maintaining a relatively 
high serum bromide level. In both groups, clearance of symptoms was 
rapid with an average time of five days; one patient was completely 
free of symptoms with a serum bromide level of 275 mg/100 ml after six 
days of niacinamide administration (152). However, Evans (1955) (17) 
pointed out that more evidence is needed to substantiate this hypothesis. 
Inorganic bromides have long been used for sedative purposes, 
and although their widespread use appears to have declined, there are 
still several organic compounds containing bromine in common use as 
sedative and hypnotic drugs. The most notable of these are the two 
87. 
bromo-ureides, carbromal (bromo-diethylacetylurea) and bromvaletone 
(bromo-dimethylpropylurea). Several proprietary lines of sleeping 
tablets, including "Relaxa-Tabs", contain one or both drugs (132). 
TOXICOLOGY. 
It has been shown that administered bromide acts as a 
sedative, while it is a known fact that the prolonged intake of large 
doses of bromide usually leads to bromide intoxication. According to 
Evans (17) bromide intoxication may be defined as a state of disordered 
mental and physical function in which there is (1) a raised serum 
bromide level, and (2) recovery when excess bromides are eliminated 
from the body. Acute bromide intoxication is said not to occur, as it 
is not possible to take a single poisonous dose of bromide without 
producing vomiting; hence the term, bromide intoxication, always 
implies a chronic condition. 
Mental symptoms of bromide intoxication are, in the mildest 
cases, dullness, fatigue, difficulty in concentration and headache. 
When intoxication becomes more severe the disturbance in mental 
functioning reaches psychotic proportions, e.g. disorientation and 
hallucinations, and neurological symptoms such as slurred speech and 
tremor of the hands may also be present (17). 
It was thought that there exists a threshold in the serum 
bromide level above which symptoms of bromide intoxication appear. 
However it has now been recognised that, although symptoms of bromide 
intoxication are usually associated with a high serum bromide level, 
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there is no uniform threshold at which symptoms appear. Barbour (153) 
reported one patient with a serum bromide level of 380 mg/100 ml 
•(normal 0 - 2.0 mg/100 ml, according to different authors) without any 
clinical evidence of bromide intoxication. On the other hand, 
Campbell (154) observed severe symptoms with a serum bromide level of 
only 50 mg NaBr/100 ml. There are other authors who agree that there 
is no correlation between bromide intake and the severity of mental 
symptoms (155, 156, 157). Thus it is now recognised that there are 
individual 'variations in the physiological effect of bromide, and that 
the appearance of symptoms of bromide intoxication may be influenced by 
several factors such as age, the presence of vascular and renal disease, 
the duration of bromide intake, the intake of chloride, the excretion 
rate of bromide, the general state of health, and the emotional state. 
Barbour (153) suggested that the simultaneous use of alcohol 
can lower the threshold considerably. Campbell (154) pointed out 
that chronic alcoholics are susceptible to bromide accumulation because 
of dehydration and a low blood chloride level. Pihkanen and Harenko 
(157) supported these findings. 
The danger of inorganic bromide intoxication has been known 
• 
for a considerable time. Nevertheless, the possible toxic effect of 
the indiscriminate use of organic bromine compounds is not widely 
realised. It has been thought by some that inorganic bromide is not 
readily freed from combination in the bramo-ureide molecule, and there-
fore is unlikely to cause a build-up of bromide, althoueh as early as 
1907 Eeckhout (158) suggested that bromvaletone could cause toxic 
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symptoms similar to those caused by inorganic bromides. Takeda (1911) 
(159) denied this and maintained that there was no danger of any toxic 
effects due to the bromide in the molecule because only a fraction of 
the bromvaletone was broken down in the body. He claimed that the 
hypnotic action of bromvaletone was due to unchanged ureide. Kwa 
(1912) (160) reported the same to be true for carbromal. 
Magnussen (1947) (161) urged caution with the use of bromo-
ureides because of their toxic effect. His experience and., since then, 
that of many others (122, 132, 162, 163, 164, 165, 166, 167, 168) who 
have treated cases of bromide intoxication due to the intake of bromo-
ureides strongly supported the original suggestion of Eeckhout. 
Shaw and Shaw (169) found a similar increase in the serum 
bromide level for a comparable daily intake of bromo-ureide and 
inorganic bromide. Trethowan and Pawloff (163) compared the rise of 
the serum bromide level in a group of human subjects who were on a daily 
intake of potassium bromide with a second group which was given a 
comparable amount of bromine in organic form, viz. Sedexin tablets. 
(Sedexin is a preparation identical to "Relaxa-Tabs" containing carbromal 
and bromvaletone in a 3 : 2 ratio.) They concluded from this 
experiment that, in the initial stages - at least, bromo-ureide preparations 
produce a rise in the serum bromide level of a similar order to that 
Obtained by the administration of an equivalent amount of inorganic 
bromide. 
The toxic effect of the bromo-ureides has been found to be 
90. 
associated with varying serum bromide levels, e.g. similar individual 
variations have been observed just as with the intake of inorganic 
bromide. Ronald (170) reported a case where carbromal intoxication 
occurred without any rise in the serum bromide level. Similar cases 
were reported by Kay and Copas (162) and Pihkanen and Harenko (157). 
Although Andrews (122) also had 19 patients with a known history of the 
intake of bromo-ureides who had a normal serum bromide level, 
nevertheless this author concluded from the results of a seven-year 
survey of 400 patients that amounts of bromo-ureidss well within the 
recommended dosage, if taken consistently for many months will produce 
high bromide levels in the serum. The toxic effect from bromo-ureides 
was more often associated with comparatively low serum bromide levels 
than has been the case with inorganic bromides (122). Similar results 
were associated with a serum level between 30 - 100 mg Br/100 ml (132, 
157, 163). This could indicate that the ureide itself, or some 
derivative thereof, is toxic without its being metabolised in the body 
to yield inorganic bromide. However, as Kay and Copas (162) pointed 
out, not all patients taking inorganic bromide develop high blood 
bromide levels. It is to be expected therefore that patients 
metabolising bromo-ureides to inorganic bromide need not necessarily 
have a high blood bromide level before toxic manifestations occur. 
The results of the survey by Andrews (122) on 400 patients 
91. 
showed that in at least 148 of these the raised serum bromide level was 
found to be definitely connected with an intake of bromo-ureides, mainly 
"Relaxa-Tabs". However the result showed considerable individual 
variation in the effects associated with various dosage levels of bromo-
ureidas. Some patients appeared to accumulate bromide from the bromo-
ureide molecule much faster than others; again the reasons for this 
were several, but one of these was found to be the simultaneous intake 
of other drugs including alcohol. 
There appears to be some uncertainty whether the toxic action 
of carbromal and bromvaletone is different from that of inorganic 
bromide, although Settler (171) maintained that there is a difference. 
However, Copes et al. (1959) (132) point out that it is difficult to 
distinguish between their effect on the nervous system and the classical 
picture of bromism. Nevertheless, there are two points of difference 
to be mentioned. Firstly, carbromal and bromvaletone appear to be 
toxic to the retina whereas this change has not been observed in 
epileptic patients who have been treated with considerably larger doses 
of inorganic bromide. Crawford (166) also reported that a man taking 
from 130 to 260 mg carbromal daily for five years was found to have 
reversible cataracts which were cleared in approximately eight weeks 
from the time his carbromal was discontinued. Secondly, the akin 
reaction produced by carbromal in susceptible subjects is unlike the 
eruption of bromism (172). 
It seems that the ureide molecule itself, or some closely 
related organic metabolite, exerts a hypnotic effect. Although it is 
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usually consilered that the toxicity of the ureide molecule itself is 
low, nevertheless, as the above evidence indicates, large doses could 
be responsible for serious symptoms. 
Andrews (122) showed that some patients who had been on large 
doses of bromo-ureides showed the toxic symptoms which are characteristic 
of bromism. However, in some other cases it was not possible to be 
sure how much of the effect was due to the bromo-ureide molecule and how 
much to the bromide released from it. It could be concluded therefore 
that these organic bromide compounds probably act on the central nervous 
system in two ways, viz, due to the release of inorganic bromide from 
the organic molecule and the effect of the ureide molecule itself. The 
resulting toxicity may thus be due to both moieties ) although released 
bromide is more toxic, mainly because it tends to accumulate in the body. 
The treatment of bromide intoxication is to discontinue bromide 
medication and to administer sodium chloride 8 - 12 g per day by mouth 
together with 4. litres of water daily. 
In recent years, many articles (163, 173, 174) have appeared 
in the medical literature of a number of countries drawing attention to 
the risk of bromide intoxication derived from continuous bromide 
medication in various forms. Most of the warnings have come from the 
medical staffs of mental hospitals. They stress that bromide intoxica-
tion is still quite common as bromide, especially in tablet form, is 
often prescribed by general practitioners, and in addition, since bromide 
preparations can be bought over the counter in any pharmacy, self 
medication with these substances is also quite common. However, as 
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Trethowan and Pawloff (163) point out, there are different opinions 
about the desirability of allowing this state of affairs to persist. 
Some feel that steps should be taken to prevent the occurrence of 
bromide intoxication by a restriction on the free sale of these prepara-
tions, while others are of the opinion that as bromides are relatively 
"harmless", undue restriction on their sale may cause those who wish to 
tranquillise themselves to resort to more pernicious preparations. 
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PRESENT INVESTIGATION 
AIMS. 
(a) To study  the effect of bromide intoxication in the human. 
(1) To discover whether the serum bromide level is associated 
with an increase in the urinary excretion of porphyrins in humans, as 
Harris and Derian (152) claimed in the case of dogs.and man. 
(2) To investigate cases of bromide intoxication. 
(b) To study the effects of bromide administration in guinea-pigs. 
(1) To determine whether the relatively long administration of 
bromide (and fluoride) has any significant effect on the serum level of 
sodium, potassium and particularly chloride. 
(2) To estimate the acetylcholinesterase level in the red blood 
cells of animals treated with bromide (and fluoride). This enzyme is 
present in several tissues, but mainly in erythrocytes and nerve cells. 
Acetylcholine, a mediator of nerve impulses, is hydrolysed. by this 
enzyme to give choline and acetic acid; accordingly this enzyme is very 
important in the generation and propagation of nerve impulses. As has 
been stated bromide acts on nerve cells, and the question arises whether 
there is any relationship between a high bromide (and fluoride) content 
in the body and the level of the above enzyme in red cells. 
(3) To estimate alanine amino transferase, previously called 
glutamic pyruvic transaminase (GPO, and serum protein fractions to find 
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out whether there is a possible effect of bromide intake on the liver. 
It is a well known fact that diseased liver cells release 
large quantities of an enzyme (GPT) which turnsa-ketoglutarate in the 
presence of alanine into pyruvate and glutamate, i.e. 
GPT emc -ketoglutarate + alanine ■■40 pyruvate + glutamate. 
The value of the determination of serum CPI' as an aid in the diagnosis 
of damaged hepatic cells has been well established.. The estimation of 
the GPT level in bromide and fluoride treated animals as compared with 
the level in untreated controls would give some indication whether the 
bromide and fluoride administered had any deleterious effect on liver 
tissue. 
METHODS AND RESULTS. 
(a) (1) Three human subjects with bromide intoxication were 
investigated. Their serum bromide levels were measured, and 24. hour 
urine specimens were collected from each for porphyrin estimation, on 
admission to hospital. In addition these same tests were carried out 
on subject C daring NaCl therapy at intervals of 8 and 16 days from the 
commencement of treatment. The results of these tests are shown in 
Table 20. 
In the case of patient B the serum bromide level dropped to 
41.6 mg/100 ml in approximately 3 weeks of NaCl therapy. At this stage 
the bromide and chloride levels were measured in the urine and in the 
TABLE 20 
Porphyrin Excretion in 3 Humans with Bromide Intoxication  
Subject 
1, 
(On 
admission) 
2, 
(8 days 
after 
3. 
(16 days 
after 
NaC1 
therapy) 
NaC1 
therapy) 
Sex F M M 
Age 32 72 32 
Serum bromide level 
mg/100 ml (N = 0 - 2,0) 160 178 170 72 28 
Total urinary volume 
m1/24 hrs. 4,125 1,620 1,050 1,450 1,275 
Coproporphyrin 
mg excreted in 24. hrs. 170 120 80 160 100 
(N = 100-250 mg/24. hrs) 
Uroporphyrin 
mg excreted in 24. hrs. Nil Nil 35 24. 12 
(N = 0 - 60 mg/24. hrs) 
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serum. The purpose of these estimations was to determine the ratio 
R urine/R serum during Nan therapy: 
m-eq Br/1 urine  where R urine - (m-eq Br/1 urine + m-eq C1/1 urine) 
m-eq Br/1 serum  and. R serum - (m-eq Br/1 serum + m-eq C1/1 serum) 
The figures for this were: 
R urine = 0.0222 
R serum = 0.0415 
therefore R urine/k serum = 0.53. 
(2) Bromide intoxication: 
The serum bromide level was estimated by the chemical method 
in three patients showing signs of bromide intoxication, and each had a 
serum bromide level above 150 mg/100 ml. In each case the bromide 
intoxication was found to be due to the intake of organic bromine in the 
form of Relams,Tabs over periods of several months. These patients 
were treated by NaC1 therapy and during a period of several weeks their 
serum bromide levels dropped to almost normal. 
(b) Experiment on Guinea-pigs. 
In this experiment guinea-pigs were divided into three main 
groups: 
1st control group, i.e. no addition of bromide to drinking 
water. 
2nd group 	400 p.p.m. of bromide added to drinking 
water in the form of KBr or liar. 
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3rd group 	5 p.p.m. of sodium fluoride added to 
drinking water. 
The number of animals in each group varied from 8 to 20. Each group 
was divided into several sub-groups of usually two animals per cage. 
After approximately eight weeks under the above conditions the animals 
were bled by heart puncture for analysis of the blood components listed 
below. 
(1) Serum electrolytes: 
Most of the sodium and potassium estimations were performed 
on an Eel flame photometer and the chloride levels were estimated by the 
mercuric nitrate titration method of Schales and Schales (146). The 
remaining electrolyte levels and the total serum protein levels were 
measured on a Technicon Auto-analyser (175). 
(2)Acetylcholinesterase: 
An electrometric method for the determination of red blood 
cell cholinesterase activity was first described by Michel (1949) (176) 
and modified by Burman (1962) (177). It involves measuring the decrease 
of pH that occurs when acetylcholine is incubated with the enzyme in a 
standard buffer. Acetic acid is liberated from acetylcholine, and thus 
a fall in pH is produced. This drop in pH is linear with time for the 
first 30 minutes, the fall being proportional to the amount of enzyme 
present. The red blood cells containing cholinesterase are haemolysed 
in saponin solution to release the enzyme. The pH was measured on a 
Radiometer pH meter model 27 B, Design 2. 
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(3) Serum CPT estimation: 
The colorimetric method of Reitman and Frankel (178), modified 
by Newfield (179), was used. This method is based on the great 
difference in absorption at 505 mu of an alkaline solution of the 2, 4.- 
dinitrophenylhydrazone of ot-ketoglutarate, as compared with that of 
pyruvate. With an increase in pyruvate and a concurrent decrease in 
vt-ketoglutarate, the resulting increase in optical density is proportion-
al to the pyruvate that is produced. Electrophoretic patterns of the 
serum proteins on one animal from both the control and bromide group 
were also obtained. Figure 16 shows that there is no difference 
between the two patterns. The results of electrolytes, cholinesterase 
and GPT estimation are shown in Table 21. 
The serum bromide level was estimated in most guinea-pigs. 
In the bromide group it varied from 350 - 420 ug/M1; in the control 
group it was within the normal range of 4.5 - 11 ug/M1, and in the 
fluoride group it was slightly lower than in the control gr 	(4. 0 - 
7.5 ug/i1). 
DISCUSSION.  
(a) (1) It can be seen from the figures presented above that the 
amounts of porphyrins excreted were well within the normal ranges. These 
results are at variance with the findings of increased porphyrin excretion 
in both dogs and man by Harris and Derian (152). However, in the present 
study only 3 cases were examined and the highest serum bromide level was 
ELECTROPHORETIC PATTERNS OF GUINEA PIG SERA 
Fig. 16 
NORMAL 
TREATED 
TABLE 21 
THE INFLUENCE OF BROMIDE AND FLUORIDE INTAKE  
ON SOME BLOOD COMFONENTS 
Control 
400 ppm Br in 
drinking water 
(8 weeks) 
5 ppm F in 
drinking water 
(8 weeks) 
Test No. of specimens Range 
No. of 
specimens Range 
No. of 
specimens Range 
Na 
(m-eq/l) 20 132-146 9 132-150 8 133-155 
K 
(m-eq/l) 12 5-7.2 5 4,4,7.9 4 5.3-7.6 
Cl 
Om -eq/l) 20 97-116 102-122 6 100-120 
Total protein 
(g/100 ml) 15 4,0-5.9 3 4.6-5.3 3 4,2-5.8 
Cholinesterase 
(units/M1 red 
blood cells) 
11 1.3-2,6 11 1,3-2.8 5 1.0-2.2 
G.P.T. 
(R and F units/ 
ml) 
20 30-98 6 44-220 5 30-74. 
. . A 
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178 mg/100 ml. This level is significantly lower than the 300 mg/100 ml 
of the previously quoted authors, and this may account for the different 
results. 
Another point worthy of mention in connection with the patient 
in question is the R urineA serum ration, where R is the ratio of 
Br  bromide to bromide plus chloride, i.e. (Br C1) Although the serum + 	. 
bromide level dropped from 178 mg/100 ml to 41.6 mg/100 ml during four 
weeks of NaCl therapy, R urine/R serum was still well below unity, i.e. 
0.53. This occurred despite the considerable increase of total bromide 
excreted in the urine (i.e. 250pilml as compared with the average 
5.Qpg/m1 in a normal human). This supports the view of Palmer and 
Clarke (23) and Evans (17) that NaC1 therapy in bromide intoxication 
causes an increase in the total halide excreted; the absolute amount of 
bromide excreted is increased. 
(2) Despite the fact that only 3 cases of bromide intoxication 
were analysed, these findings nevertheless indicate the danger of the 
indiscriminate use of various sedative drugs containing bromine. One 
patient had been taking one of these preparations for several months and 
was even carrying the tablets on admission to hospital. 
(b) During the first two weeks of the experiment less water was drunk 
by the fluoride group and even much less again by the bromide group than 
the control animals. This presumably was due to the ta*e imparted to 
the water by the addition of fluoride and bromide. However, after a 
fortnight both groups drank approximately the same amount as the control 
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group. In the bromide group, there was no evidence of bromide 
intoxication beyond a slight sluggishness in the movements of the 
animals, while the fluoride group showed no effect at all. 
After two months, the serum level inthe bromide group of 
animals was 35 - 42 mg/100 ml, a relatively high level for guinea-pigs, 
but apparently not high enough to cause bromide intoxication. 
(1) The serum electrolyte level in normal guinea-pigs, when 
compared with that of humans, shows that the sodium level is about the 
same, viz.: 132 - 146 m-eq/1 in guinea-pigs as against 150 - 145 m-eq/1 
in humans. The potassium figures for guinea-pigs are slightly higher, 
viz.: 5 - 7.2 as against 3.5 - 5.5 m-eq/l, but since a certain small 
degree of haemolysis was unavoidably present in the specimens, this 
difference could be due to this factor. The chloride level, however, 
shows a pronounced difference as the analysis of specimens from 20 
animals showed the range in guinea-pigs to be from 97 - 116 m-eq/1 while 
the normal human range is 95 - 108 m-eq/1. The total serum protein 
level on the other hand is lower in guinea-pigs, with a range of 4.0 - 
5.9 g/100 ml as compared with the human range of 6.2 - 7.6 g/100 ml. 
The investigation of the individual fractions of serum 
proteins shows that there is not much difference in the albumin and the 
albumin-globulin ratio as seen from Table below. In this table the 
percentage of individual fractions of the total protein is given for 
normal humans, one normal guinea-pig and one guinea-pig on bromide. 
The table shows that, whereas the largest globulin fraction in humans is 
the 4'-globulin, in guinea-pigs it appears to be 0( 2 component. 
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Comparison of Serum Protein Fractions in Humans and Guinea-pigs 
(as % of Total Protein)  
Normal human Normal guinea-pig Guinea-pig from bromide group 
Albumin 54 - 66 58 55 
be. 1 globulin 3 - 	6 2 4. 
NoL 2 globulin 5 - 	9 25 24 
4 globulin 9 - 15 10 11 
( globulin 11 - 22 5 6 
Total serum globulin 31 - 52 42 45 
Albumin/globulin ratio 1.2 - 2.0 1.38 1.22 
In considering the effect of bromide and fluoride on the above 
electrolytes, the results obtained indicate that the intake of bromide 
and fluoride in the amounts given have no significant effect on the 
serum electrolytes and total serum protein level. Any mall variations 
shown between the three groups could be attributed to the individual 
variations between the animals, and possible experimental error. It 
appears that the sodium and potassium ingested (since the bromide was 
given as the sodium and potassium salts) did not significantly alter the 
level of these ions in the serum and therefore most of the consumed 
sodium and potassium must have been excreted. The chloride levels were 
practically the same in all three groups, but as it is known that 
bromide can replace chloride from the tissue and blood )one would expect 
the chloride level in the bromide group to be lower than in the control 
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group. In actual fact, the figures for the bromide group are slightly 
higher. However it must be remembered that the serum bromide level of 
35 - 42 mg/100 ml represents from 4.4 - 5.2 m-eq/1. The figures for 
the chloride level in the bromide group are on the average 5 m-eq/1 
higher compared with the control group. This can be simply explained 
by the fact that the mercuric nitrate titration method used for the 
chloride estimation does not differentiate between chloride and 
bromide, hence the extra bromide 5 m-eq/1 in the bromide group has been 
measured as chloride, and hence the higher figures for chloride were 
obtained. Actually, the true serum chloride levels in both groups 
remain about equal. This shows, however, that at the above serum 
bromide level actual replacement of chloride is not significant. 
(2) The level of acetylcholinesterase activity in normal guinea-
pigs of from 1.3 - 2.6 units/m1 of red blood cells is much lower than 
the normal human level of 6.8 - 12.2 units/ml of red blood cells. This 
perhaps would be expected in view of the higher development of the 
human central nervous system. 
The level of acetylcholinesterase activities was almost 
identical in all three groups, which indicates that there is no direct 
effect of bromide or fluoride in the given doses on this enzyme. The 
slight decrease of the level of activity of this enzyme in the fluoride 
group may not be significant because only five samples were examined as 
against 11 in both the bromide and control groups. 
(3) The serum GPT level in the 20 normal guinea-pigs examined 
showed a range of 30 - 98 R. and F. units/ml, which is higher than the 
103. 
generally accepted range in normal human serum (5 - 35 R. and F. units/M1 
The dose of fluoride administered did not have any effect on 
the above enzyme, and it is probable that no effect on the GPT level 
could be attributed to the administration of bromide. The serum CPI' 
level in the latter group ranged from 44 - 220 R. and F. units as 
against 30 - 98 in the control group but there were only two animals 
with serum GPT levels above the normal range. The actual figures in 
the bromide group were: 
44, 58, 84, 85, 130 and 220 R. and F. units/ml. 
The two highest levels could possibly be due to liver damage caused by 
some other factor than that of administered bromide. However the 
secondary and supplementary effect of bromide in these animals cannot be 
excluded, although conclusive evidence cannot be presented at this stage 
to show that bromide causes any damage to liver cells and thus liberates 
GPT into the serum. 
The electrophoretic pattern of aa, animal from the bromide 
group was identical with that of a control animal. This would be 
further evidence that prolonged administration of bromide in the doses 
used does not affect the liver, which is a very important site of serum 
protein production. 
Therefore it can be concluded that there is no evidence to 
suggest that bromide and fluoride administered in the doses given have 
any significant effect on the level of the serum electrolytes, the total 
serum protein or the two enzymes, acetylcholinesterase and alanine amino 
transf erase. 
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